Hair and Scalp Health: O 1 Hair and Scalp Health for the Dermato-trichologist

Zoe Diana Draelos

North Carolina, USA

Healthy hair occurs when the scalp is healthy. Several activities can damage the hair. Heat is commonly used on the hair to dry wet hair and for hair styling. The exposure of the hair to high heat results in denaturation of the hair proteins, which weakens the hair shaft through the formation of bubbles. These bubbles are created when the water in the hair shaft changes from liquid to gas and pops off the cuticular scale as it escapes. The cuticular scale can also be removed by scratching of the scalp. Since it is impossible to scratch the scalp without scratching the hair, seborrheic dermatitis may result in hair loss. After 45 min of scratching, the cuticle is completely removed from the hair shaft. Elimination of the malassezia globosa and malassezia restricta is the key to controlling seborrheic dermatitis and minimizing hair damage from scratching.

Hair and History: O 2 Human Hair Evolution

Prashant K. Palwade

Aurangabad, India

Hair of different mammals is often distinctly different. All primates have thick, coarse hair, and explanations as to how this fur was lost in human evolution are deficient and contradictory. In humans, evolution has selected shorter and finer body hair and only the head hair remains in large quantity. This island (head) of human hair is capable of growing to greater lengths than that of any other mammal. There is a proposition that we will see more of less hairy men and women, less of facial hair in men, and more of early age androgen-dependent hair losses as we continue to shed our hair over the next few centuries.

O 3 Ancient Indian Pilo-philosophy

Sreekanth S.

Calicut, India

Let us aim to find what ancient Indian scriptures can contribute to the Dermato-trichologist, especially in a philosophical point of view. Ancient Indian scriptures like the "Upanishads" and "Puranas" were analyzed critically, regarding mentions about both hair and mind, and it was viewed in the background of modern scientific knowledge. The sequential stages of development of embryo are described in the Purana called "Bhagavata" in a manner more or less similar to the modern scientific knowledge. Of interest to trichology is that the periods of embryonic development of skin and hair are also mentioned almost correctly. The ancient Indian literature had also recognized the intimate relation between mind and the processes inside the body. The similarities observed between the concepts envisaged in the ancient Upanishads and the recent concept of using "mirror neurons" in the treatment of phantom limb and many other recent theories about matter and energy are worth studying. A multidisciplinary analysis of the available knowledge, in the fields of medicine, metaphysics, and philosophy is essential for a comprehensive outlook. Ancient Indian literature also can contribute to this.

O 4: Hairy Tales from the Bible

Patrick Yesudian

Chennai, India

History is important in all aspects of life, be it in the humanities, medicine, or even religious history. As Sir Winston Churchill said, "The longer you can look back, the further forward you can see." So, we can learn many new things from history. It is from this perspective that a few stories from the Bible, relevant to trichology, will be discussed -- cases of hypertrichosis, baldness, trichotillomania, and canities are all found in the Bible. Even hair cosmetics are mentioned. An overview of these stories would constitute an interesting aspect of trichology.

Hair and Kids: O 5 Hair Loss in Children

Antonella Tosti

Miami, USA

This presentation will discuss the most important causes of hair loss in children. These include genetic and acquired disorders. Genetic disorders are characterized by hair shaft breakage and are usually evident during the first few years of life. Monilethrix is the most common and its severity can considerably vary among different family members. Acquired disorders diagnosed in childhood include loose anagen and short anagen syndrome, both characterized by short and sparse hair. Alopecia areata is common and present since birth.

O 6: Hypertrichosis and Hirsutism in Children

Deepak Parikh

Mumbai, India

Hypertrichosis is hair growth that is abnormal for age, sex, or race of an individual and/or particular area of the body. Hirsutism is a sub-class of hypertrichosis, caused by androgen-dependent male pattern hair growth in female child. Most of the time, hypertrichosis involves switch from vellus to terminal hair. However, the exact reason for such switch is poorly understood. Currently it is classified as congenital or acquired and then as localized or generalized. Hirsutism in children is uncommon. Detailed examination and investigations may be required to evaluate androgen-dependent changes. Polycystic ovarian syndrome, though uncommon, can occur in adolescents.

O 7: Pearls in Pediatric Trichology

Paul Devakar Yesudian

Ysbyty Glan Clwyd, UK

Hair disorders in children are rare. However, when it occurs, it causes significant distress not only to the child but also to the families involved. A variety of inflammatory and non-inflammatory dermatoses can predispose to trichological problems in childhood. A few case reports of pediatric trichology disorders will be discussed in this section.

Best off the Bench: O 8 Melanin Transfer -- Message for the Clinician

Desmond J. Tobin

Bradford, UK

Transfer of the melanocyte-specific melanosome from melanocytes to keratinocytes is required to protect our skin against harmful ultraviolet (UV) irradiation. However, this everyday event remains enigmatic, despite several hypotheses suggesting cytophagocytosis of melanocyte dendrites by keratinocytes and exocytosis of melanin granules. Recently, we and others have proposed a role for nanotubular structures called "filopodia" in melanin transfer. Using known markers of filopodia (e.g. MyoX and Cdc42) and the filopodium disrupter cytochalasin-B, we demonstrated a requirement for filopodia in melanosome transfer *in vitro*, not only from melanocytes to keratinocytes but also remarkably between keratinocytes. Filopodia were also necessary for melanosome transfer induced by UVR. By contrast, elimination of filopodia from keratinocytes alone did not inhibit UV-induced melanosome transfer from untreated melanocyte filopodia. Melanin uptake into keratinocytes via phagocytosis of melanocyte filopodia was shown when knockdown of phagocytosis-disrupter MyoX in keratinocytes blocked melanin uptake. Here, melanocyte filopodia-associated melanosomes were prevented from completing transfer into keratinocytes and these instead accumulated at the keratinocyte plasma membrane. We have recently examined the role of certain members of the bone morphogenetic protein (BMP) family as potential modulators of pigmentation. BMP-6 was able to stimulate, while BMP-4 inhibited melanogenesis, in part by modulating filopodial involvement in melanin transfer. Modulation of melanocyte filopodia and/or keratinocyte phagocytosis may be useful in the treatment of hyper- and hypopigmentary conditions of these disorders.

Hair Loss in Pattern: O 9 Perifollicular Micro-inflammation in Pattern Hair Loss

Ralph M. Trüeb

Zurich-Wallisellen, Switzerland

In pattern hair loss (PHL), the genetically predisposed hair follicles are susceptible to androgen-stimulated hair follicle miniaturization, leading to replacement of large and pigmented hairs by barely visible, depigmented hairs. The result is a progressive decline in visible scalp hair density that follows a defined, age- and sex-dependent pattern. Major advances have been achieved in understanding peculiarities of the androgen metabolism involved. Nevertheless, clinical practice has shown that simply blocking androgens has limited success. On histologic examination, the miniaturization of terminal hairs is frequently associated with perifollicular inflammatory phenomena and fibrosis. Therefore, sustained microscopic follicular inflammation with connective tissue remodeling, eventually resulting in permanent hair loss, is considered a possible cofactor in the etiology of PHL. There seems to exist a continuum of inflammatory phenomena and fibrosis in PHL, reaching from microscopic follicular inflammation and fibrosis (Jaworsky *et al*., 1992) to localized phenomena in frontal fibrosing alopecia (Kossard, 1994) and a more generalized pattern in fibrosing alopecia in a pattern distribution (Zinkernagel and Trüeb, 2000). So far, the inflammatory component has not been included in the treatment protocols for PHL. Besides androgens and genetic imbalance, additional pathogenic factors are now suspected, such as microbial flora, endogenous and exogenous stress, micro-inflammation, and possibly others. Dissecting the molecular controls of immune-mediated, physiological hair follicle degeneration by apoptosis-mediated organ deletion could provide insights into how progression of some forms of permanent alopecia might be halted, which can be suppressed with only limited success by the current treatment modalities. This could also hold true for further studies in PHL with microscopic or clinical evidence of inflammatory phenomena and fibrosis.

O 10: The Mechanisms of Androgen Action and How They Effect Hair Growth

Valerie Anne Randall

Bradford, UK

Androgens, the male sex hormones, regulate most changes in human hair growth. Pubertal increases in circulating androgens stimulate tiny vellus follicles, producing almost invisible hairs, to enlarge, forming large, pigmented, pubic and axillary hair in both men and women. These signal developing sexual maturity. Men\'s higher androgen levels also promote greater body hair, particularly the characteristic beard which clearly identifies adult males. Since communication is such an important role of human hair, any hair growth abnormalities cause psychological distress. This happens whether disorders involve increased hair, like hirsutism (male pattern hair growth in women), or hair loss, e.g. androgenetic alopecia (male pattern hair loss). Androgens drive hair enlargement at puberty and in hirsutism, and in contrast, the miniaturization of scalp follicles. In men, androgens cause a slowly progressive inhibition of hair follicles with vellus hairs replacing terminal ones starting at the frontal hairline and spreading over the top of the head. The female pattern usually differs with diffuse hair loss and retention of the frontal hairline. This paradoxical androgen stimulation of hair growth and balding in the same person indicates different responses to the same hormones within follicles. All androgen-dependent follicles contain the intracellular androgen receptors essential for androgen action. However, only some, including facial and balding scalp follicles, also contain 5α-reductase type 2, an enzyme responsible for metabolizing testosterone into the more potent 5α-dihydrotestosterone. Both 5α-reductase and androgen receptors are found in the hair bulb in the dermal papilla. Androgens probably act by altering the dermal papilla\'s production of paracrine regulators which then change the activity of the keratinocytes that form the hair and the melanocytes that produce the pigment. Currently, drugs which block androgen binding to androgen receptors, e.g. cyproterone acetate, are available for women (with contraception), and 5a-reductase type 2 competitors, e.g. finasteride, can be more selective inhibitors of specific follicles e.g. male balding scalp. Further understanding of follicular androgen action should lead to novel, more specific therapeutic approaches.

O 11: Female Pattern Hair Loss

A. G. Messenger

Sheffield, UK

Female pattern hair loss (FPHL) and male androgenetic alopecia (MAGA) share a common pathology, but there is increasing evidence that their etiology is not necessarily identical. Twin studies show that the predisposition to MAGA is mainly genetic. A twin study in women found that frontal recession is also mainly due to genetic factors but showed no genetic component to hair thinning. Similarly, a genetic study in FPHL from Germany and the UK found no association with chromosome 20p11 and only weak association of AR/EDA2R with early-onset hair loss -- both 20p11 and AR/EDA2R are associated with MAGA. The role of androgens in FPHL is also uncertain. Scalp hair loss may be a feature of female hyperandrogenism, but a recent study from the USA reported improvement in hair growth in androgen-deficient women receiving testosterone replacement. Although there may be commonality between men and women in the etiology of early-onset hair loss, it is apparent that we should be looking beyond androgens and genetics in the search for causes of FPHL.

O 12: What\'s New in Female Pattern Hair Loss

Niti Khunger

New Delhi, India

Female pattern hair loss (FPHL), formerly called as female androgenetic alopecia (FAGA), is the most common form of hair loss, affecting up to 50% of women by the time they reach their 50s. There are several differences between male pattern hair loss and FPHL, and concepts in pathophysiology of FPHL are changing in recent times. The role of androgens in FPHL has not been clearly established and estrogens are postulated to play a bigger role. The recent concept is the relative importance of estrogen in FPHL pathogenesis remains widely underestimated and may even exceed that of androgens. Prolactin may also play a role as human scalp hair follicles are both a target and a source of prolactin, which has potent hair growth modulatory properties. Recent preliminary evidence suggests that the effects of prolactin on human hair follicles may be quite gender- and/or site-specific. Another important concept is the association between metabolic syndrome and FPHL appears to be significant in females. A new genetic test in the androgen receptor gene has been recently introduced to predict risk for androgenetic alopecia in women. There is evidence that the occipital area may also be involved in FPHL, unlike male pattern hair loss (MPHL). Inflammation and immunity may also play a larger role in a select group of patients as a lymphocytic microfolliculitis targeting the bulge epithelium are frequent findings in FPHL, paving the way for combined modalities of treatment. Platelet-rich plasma, stem cell therapy, a 1550-nm fractional erbium-glass laser, high-dose finasteride, mesotherapy with dutasteride, injected bimatoprost 0.03%, hair growth peptides, bioengineered, nonrecombinant, human cell-derived formulation containing follistatin, keratinocyte growth factor (KGF), and vascular endothelial growth factor (VEGF) are some of the newer treatments targeted toward FPHL.

O 13: Finasteride in FPHL -- Dose, Duration, Dogmas, and Dilemmas

Rajetha Damisetty

Hyderabad, India

Female pattern hair loss (FPHL) has enormous psychological impact, much more than that of male pattern hair loss (MPHL) which is more socially acceptable. The pathogenesis of FPHL is still poorly understood. Its frequent occurrence in normo-androgenic women, both in the reproductive and postmenopausal age groups, has added to the mystery. Treatment options include minoxidil, androgen receptor antagonists (spironolactone, cyproterone acetate, flutamide), and the 5a-reductase inhibitor finasteride. All the oral medications are either impractical for use beyond 6--12 months or are fraught with serious adverse effects such as hepatotoxicity (flutamide), the only exception being finasteride. Finasteride had gained bad publicity due to its lack of therapeutic effect when 1 mg was used, especially in women with normal androgen sensitivity, evidenced by ≥24 CAG repeats in exon 1 of the androgen receptor (AR) gene. However, current evidence reveals that higher doses work in FPHL. While it is still under debate whether 2.5 mg is as good as 5 mg finasteride in women for FPHL, it is clear that 1 mg does not work. The general stand is that finasteride is contraindicated for women with reproductive potential as it can feminize the male fetus. It can safely be given to women who are postmenopausal or have undergone tubectomy. For women who want to conceive in future but fail to respond to minoxidil, finasteride, a category X drug, may be used along with reliable contraception with a 6 months wash-out period before conception. A 12-month trial is needed to assess stabilization of hair loss while regrowth may take 2 years or longer.

Hair and Therapy: O 14 New Horizons in the Treatment of Hair Disorders

Antonella Tosti

Miami, USA

There is good evidence-based information for the treatment of androgenetic alopecia. There are very few good-quality randomized studies, and no information about long-term results for most of the available treatments for alopecia areata and cicatricial alopecias. Significant research success has been achieved over the past few years through (i) discovery of the genetic profile of alopecia areata; (ii) working on follicular neogenesis in androgenetic alopecia; and (iii) discovering the PPAR-g pathway in scarring alopecia.

O 15: Potential New Therapies for Androgenetic Alopecia

Rachita S. Durat

Mumbai, India

Efficacy of finasteride in Merck study was 66%. Reported efficacy of minoxidil in various studies ranged from 40 to 50%. Substantial number of patients with androgenetic alopecia showed no growth of new hair, despite the above conventional therapies which mainly target dihydrotestosterone enzyme. This has led many researchers to study the other possible pathogenic mechanisms in androgenetic alopecia apart from dihydrotestosterone mechanism. The latest breakthrough in understanding of the pathogenic mechanisms involve a crosstalk of many paracrine factors at different hair cycle stages with various signaling pathways involving Wnt/β catenin, pERK, DKK, and Bcl2 pathways, and wound growth factors like vascular endothelial growth factor (VEGF), FGF, and KGF. Newer developments in treating androgenetic alopecia include use of platelet-rich plasma, oligopeptides, and decapeptides, Noggin, copper peptides, Wnt protein, micro-needling, lasers, etc. These therapies regulate Wnt signaling, Bcl2, and related pathways, and thus stimulate the bulge cells and the inter-follicular stem cells, thereby reversing the miniaturization process and inducing new hair growth formation. These new therapies appear to be on the cusp of an exciting development in androgenetic alopecia.

O 16: 5α-Reductase Inhibitors -- Fear, Fiction, and Facts

Venkatram Mysore

Bangalore, India

5 alha reductase inhibitors are valuable agents in the management of androgenetic alopecia and are used routinely in practice, both as solo drugs and in combination with minoxidil and hair transplantation, particularly in men. However several aspects of the drugs have attracted attention, scrutiny , and a lot of adverse publicity. This has lead to apprehension in the minds of patients leading to refusal to take these drugs. This talk will examine the following aspects of these drugs and the evidence available:

Finasteride --sexual side effects, breast cancer in men, depression, prostate cancer and recent labelling changes by FDA and use in womenDutasteride- role, safety

The talk will also focus on possible guidelines for usage of these drugs in management of androgenetic alopecia

O 17: Therapeutic Pearls in Trichology

Chandrasekhar B S

Bangalore, India

"A hair in the head is worth two in the brush" - Oliver Herford

Treatment options for hair loss have been in vogue since time immemorial, with data regarding the same being mentioned in innumerable works. In today\'s scenario, where cosmesis plays a pivotal role in any dermatologist\'s practice, it becomes imperative to come up with innovations and improvisations, to add to the armamentarium of therapeutic options.

Though Minoxidil and Finasteride have been in use for quite a long time, there are many reasons for patients achieving suboptimal response. A judicious use of these medications along with improvisation of the existing therapies like mesotherapy, combination therapy, scalp micro wounding etc., would go a long way in improving the therapeutic outcome. These shall be discussed on a case by case basis.

Food for Hair: O 18 Hair and Nutrition

Ralph M. Trüeb

Zurich-Wallisellen, Switzerland

The quantity and quality of hair growth are associated with the nutritional state of an individual. Normal supply, uptake, and transport of proteins, calories, trace elements, and vitamins are of fundamental importance in tissues with a high biosynthetic activity such as the hair follicle. Because the hair shaft is composed almost entirely of protein, the protein component of diet is critical for production of normal healthy hair. The rate of mitosis is sensitive to the calorific value of diet, provided mainly by carbohydrates stored as glycogen in the outer root sheath of follicle. Finally, vitamins and trace metals are related to the biosynthetic and energetic metabolism of follicle. It appears that on a typical Western diet, the hair follicle should have no problem in producing an appropriate hair shaft. Nevertheless, in instances of protein and calorie malnutrition, deficiency of biotin, vitamins C, B12, niacin, essential fatty acids, iron, zinc, copper, and selenium, hair growth and pigmentation may be impaired. The nutritional defect may be due to a hereditary defect in absorption or metabolism or environmental. Response to adequate substitution is usually good. Our knowledge of the effects of nutritional deficiencies on hair derives from observations in rare inborn errors of metabolism, in undernutrition/protein--calorie malnutrition, and in specific deficiency disorders, as well as from supplementation studies in animals and humans. Since an important commercial interest lies in the nutritional value of various vitamin and amino acid supplements, a question that arises is whether increasing the content of an already adequate diet with specific amino acids, vitamins, and/or trace elements may further promote hair growth and quality, particularly in the aging hair follicle, where a physiological deficit is hypothesized. Dietary supplements are traditionally used over the counter products for treatment or prevention of hair loss. Typically, they are based on a combination of l-cystine and vitamins, usually of the B-complex group, including medicinal yeast, a rich natural source of B-complex vitamins, and pantothenic acid (CYP-complex). The rationale for the use of l-cystine is based on the biochemistry of cystine metabolism, clinical observations in disorders of l-cystine metabolism and cystine deficiency, and results of animal and human studies. In early studies, it was found that enrichment of even what appeared to be a normal diet with sulfur-containing amino acids increased wool production in sheep. Eventually, studies on the effect of CYP-complex based dietary supplements have been published, showing improvements in the trichogram, in hair swelling as a criterion for hair quality, and in the tensile strength of the hair fiber. In a double-blind, placebo-controlled study in 30 otherwise healthy women suffering of telogen effluvium, we demonstrated by means of epiluminiscence microscopy with digital image analysis that dietary supplement with CYP-complex increased the anagen hair rate within 6 months of treatment, while placebo did not.

**Further Reading**

Lengg N, Heidecker B, Seifert B, Trüeb RM. Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind placebo-controlled trial. Therapy 2007;4:59-65

Hair -- Scars and Cicatrix: O 19 Challenges in Cicatricial Alopecia

Paul Devakar Yesudian

Ysbyty Glan Clwyd, UK

Cicatricial alopecia can follow a variety of inflammatory skin conditions and one of the commonest causes is lichen planopilaris. It is characterized by perifollicular erythema and scaling which progresses on to areas of scarring alopecia when left untreated. Early recognition and treatment are vital as progression of the condition would result in permanent irreversible hair loss. In this lecture, the methods that can be used to monitor treatment would be discussed, along with the potential therapeutic agents that could be helpful. Medications that have been successfully used include hydroxychloroquine, topical and systemic corticosteroids, cyclosporin, and mycophenolate mofetil.

O 20: Non-scarring and Scarring Alopecia in Association with Kikuchi Fujimoto Disease

Krishnan Bhagwandas

Newport, UK

A rare association of alopecia areata and cutaneous lupus erythematosus in association with Kikuchi Fujimoto disease is presented. We also draw attention to the unusual targetoid pattern of regrowth of the alopecia areata and the "wave hypothesis." We offer the "waste disposal hypothesis" to explain the association of lupus erythematosus with Kikuchi Fujimoto disease. A 30-year-old Afro-Caribbean lady was referred to the dermatology department by her ENT surgeon for patchy hair loss on her scalp. When first seen by the dermatologist a few months later, the patches had spontaneously regrown. She was referred again by her ENT surgeon 2 years later for a recurrence of patchy scalp hair loss. This time she had an unusual "targetoid" pattern of regrowth of alopecia areata and also areas of scarring alopecia. She was under the care of the ENT department for a large rubbery mass on the right side of her neck, intermittent pyrexia, and malaise over a 3-year period. Histology of a right cervical lymph node showed florid necrotizing lymphadenitis consistent with Kikuchi Fujimoto disease. Her neck mass has spontaneously resolved over a 4-year period. Histology of a scalp biopsy showed features of scarring alopecia consistent with lupus erythematosus. Although she initially presented with alopecia areata, she now has extensive scarring alopecia unresponsive to anti-inflammatory therapy including systemic steroids, hydoxychloroquine, and mycophenolate mofetil. We present a rare association of non-scarring and scarring alopecia in Kikuchi Fujimoto disease.

O 21: Update on Frontal Fibrosing Alopecia

Antonella Tosti

Miami, USA

Frontal fibrosing alopecia (FFA) is a clinically distinct variant of lichen planopilaris (LPP) that mostly affects postmenopausal women and frequently involves the eyebrows and the limbs. It was shown recently that in FFA, vellus or terminal hairs of the face, including the eyelashes, as well as the limbs may also be affected by hair loss which shows the same LPP pattern on pathology. This presentation will review recent findings on epidemiology, clinical features, and treatment of this increasingly diagnosed alopecia.

Hair and Natural Color: O 22 Update on Hair Pigmentation

Desmond J. Tobin

Bradford, UK

The hair follicle is a unique epithelial--mesenchymal--neuroectodermal mini-organ at the vanguard of modern biomedical science. Our interest in the hair color phenotype sits in parallel to an understanding of the phylogenetically ancient biochemical process of melanogenesis that underpins it. Humans display a rich and highly varied palette of hair color ranging from vivid reds and sun-bleached blondes to sober browns and raven blacks. Aging adds steel grays and snowy whites to this palette. Not surprising then that hair color remains a powerful signal in social/sexual communication. During this India 2012 Lecture, I will address our current understanding of how hair pigmentation is regulated, what controls plasticity of hair follicle melanocytes' differentiation states, as well as how these neural crest-derived cells age in the skin versus the hair follicle. I will also describe how cutaneous melanocyte subpopulations differ when located in UV-exposed epidermis versus in the cycling hair follicle. It is not only relevant for our aesthetic appearance, but also provides insights into clinical conditions such as vitiligo, alopecia areata, and melanoma. While hormone responsiveness of hair follicles is well known, only recently have we seen how the human hair follicle′s neuroendocrine axis/axes may participate in hair pigmentation, as well as what this may mean for the relatedness of melanocytes with neural cells and in turn the latter′s aging in neurodegenerative diseases.

O 23: Premature Canities -- An Elusive Enigma

Najeeba Riyaz

Calicut, India

Graying is considered as a sign of aging of hair, which correlates closely with chronological aging. Graying occurs at varying degrees in different individuals regardless of gender or race. Age of onset appears to be hereditary, usually in the fourth decade. The "rule of thumb" is that by 50 years of age, 50% of people will have 50% gray hair. The average age for Asians is late 30s. Graying becomes premature if it develops before 25 years in Asians, 20 years in Caucasians, and 30 years in Africans. Autoimmune diseases like vitiligo, pernicious anemia, thyroid disorders, genetic syndromes like Progeria and Werner\'s syndrome, stress, sun exposure, radiation, pollution, and smoking are the possible precipitating factors for premature canities. Deficiency of key molecules in melanogenesis such as microphthalmia-associated transcription factor-M, Sox10, Pax3, tyrosine related protein-1 (TRP-1), and tyrosinase, defective migration of melanocyte stem cells into hair bulb, and mutations in telomerase are the other possible mechanisms. Deficiency of vitamins D3, B5, B6, B9, B12, copper, zinc, iron, iodine, protein, and para amino benzoic acid may be responsible for premature graying. A study was done to assess the role of vitamin D3 in 34 patients with premature canities. The male:female ratio was 1.1:1 and the mean age was 20.82 years. Of the 34 patients, 99.1% had insufficient levels of vitamin D3, whereas 0.9% had normal levels. Vitamin D3 levels were normal in 80% of age-matched controls, whereas 20% had low values. The study points toward a possible causative role of vitamin D3 in premature canities. Further studies are required to confirm this.

Hair and Artificial Color: O 24 Hair Dye Dilemmas

Zoe Diana Draelos

North Carolina, USA

Hair dye is commonly used by both men and women to cover gray hair and obtain hair shades different from the natural hair color. The basic categories of hair dyes are progressive, temporary, semi-permanent, and permanent. Progressive hair dyes use metal salts to create color on the hair shaft. These dyes are used primarily by men, as they cannot be combined with other hair dyes and permanent waving solutions. Temporary hair dyes are removed with one shampoo and are used to create dramatic hair effects. The longer-lasting semi-permanent dyes last for 6--10 shampooings, but can only be used to darken the hair. The most popular permanent hair dyes use dyestuffs to create color within the hair shaft and can either lighten or darken the hair color. Permanent hair dyes are now available in ammonia-free varieties to minimize hair damage. The goal of hair dyeing is to create the desired color without irreversibly damaging the hair shaft.

O 25: Hair Dye Dermatitis, Contact Sensitization, and Current Scenario

A. K. Bajaj

Allahabad, India

Hair dyes are a major hair cosmetic used by both women and men. They are used to color gray hair dark black or soft black and to add colored highlights to normal hair. The usage of hair dyes has been on the increase. In some European countries, over 70% women have been reported to use hair dyes sometime in their lifetime. In India as well, hair dyeing has become quite common. Hair dyes are of various types, viz. gradual, temporary, semi-permanent, and permanent (oxidative hair dyes). Over 70% of the hair dye market is for permanent hair dyes. In India, the introduction of black henna almost over two decades back has made hair dyeing simple and extremely cost-effective and less time-consuming. The black hennas are being touted as herbal dyes, but over and above the herbal components, they contain high concentrations of paraphenylenediamine (PPDA). Indian economy being cost-driven, black henna is being used by a large majority of middle-class population. PPDA is a well-known potent sensitizer and its use without proper precautions has led to increase in the incidence of contact sensitivity leading to severe dermatitis, eczematous eruptions, lichenoid eruptions, and even depigmentation. Temporary henna tattooing during religious and social functions is quite common in our country. Earlier henna was used for this purpose, but it was quite time consuming and would fade very fast. These days, PPDA is being mixed with henna to give bright color in a short time. This has further resulted in increase in contact sensitivity. In my clinic, the incidence of sensitivity to PPDA has gone up to 8% from 5% in the past in the patch-tested population.

Hair -- Art and Literature: O 26 Alopecia and the Arts

P. D. Yesudian

Ysbyty Glan Clwyd, UK

From time immemorial, humans have always placed immense importance in the appearance of their hair. These hairstyles have been recorded over the ages by astute artists from various eras. However, it is from the renaissance period that accurate manifestations of skin disorders, including alopecia, were translated into art. There are examples of both male and female alopecia, and the conditions that were painted include frontal fibrosing alopecia, alopecia areata, scarring alopecia from kerion, and androgenic alopecia. It is important that we not only reflect on the dermatological diagnosis, but also should pause to consider the artistic values of these priceless works.

O 27: Hair Care in Ancient Tamil Sangam Literature

Murugusundram S.

Chennai, India

The history of Tamil literature is the reflection of the history of the ancient Tamil culture. Origin of Tamil literature dates back to almost more than 2000 years, indicating one of the evolutionally antique highly civilized lifestyles that existed. Sangam literature refers to the core of classical Tamil literature created between the years c. 600 BC and 300 AD. Modern linguistic scholarship places these poems between the 1st century BC and the 3^rd^ century AD. This collection contains 2381 poems composed by 473 poets, some 102 of whom remain anonymous. The five great Tamil epics, Cilappatikaram, Manimekalai, Jivaka-chintamani, Kundalakesi, and Valayapathi, have been created from 2^nd^ century AD to 10th century AD, of which the Cilappatikaram is unique in its vivid portrayal of the ancient Tamil culture. The Sangam poems fall into the broad categories of "Akam" (inner field or subjective) and "Puram" (outer field or objective) topics. While emotional aspects such as love and relationships formed the theme of Akam, the Puram discussed issues like heroism, valor, ethics, benevolence, philanthropy, social life, and customs. The epics were stories which had all elements of drama. Depiction of hair metaphorically and description of hair care and style as anecdotes of social and emotional well-being is seen in these ancient Tamil poems right from the Sangam age. Our ancestors were well aware of the fact that healthy hair reflects healthy body. Ancient Tamil literature (600 BC--1000 AD) has amply recorded the significant value and interrelatedness which our ancestors attached to hair and its care. The central focus of this lecture is to explore the knowledge of hair care that was prevalent many centuries ago among the ancient Tamils.

O 28: Beard Hair -- The Art and Aesthetics

Satish Udare

Navi Mumbai, India

Both excess and lack of facial hair are considered as a menace. While some men adore it, there are some who show an aversion to it. There are a variety of social, cultural, and procedural concepts playing different roles in this interesting and intriguing, but not often discussed issue. The physiology, pathology, presentations, and aesthetics of the facial hair, especially the beard area, of both sexes will be discussed. Racial variations, depilatory methods, and daily shaving procedures have their own implications in leading to specific problems in hair and the underlying skin.

O 29: Aesthetics of a Hair Clinic

Poorva Shah

Pune, India

It is important to have dedicated hair clinics established by dermato-trichologist most essentially to abolish quackery in trichology. The hair clinic should be aesthetically pleasing to the anxious hair patients and should be well equipped to satisfy the needs of the patient both physically and mentally. Educative visual aids and artistic displays are welcome by the modern metropolitan society and the message is delivered with ease aesthetically. The outcome of a well-designed clinic is much better than a disorganized setup.

Interesting Clinical Studies -- Most Practical for a Dermato-trichologist: O 30 Hair and Scalp Disorders of Children in Rural India: A 2-year Retrospective Study

K.G. Divya

India

**Aim**: To study the prevalence of hair and scalp disorders affecting children. **Materials and Methods**: A retrospective study of 2 years duration (March 2010 to February 2012) was carried out in SRM hospital. All children aged less than 16 years with lesions affecting the scalp and hair were included in our study. The relevant investigations were done. **Results**: Of the total 2880 children studied, 316 children (11%) had hair and scalp disorders. Ninety-eight children had bacterial pyodermas of the scalp (31%) and 20 had fungal infections (6.3%). Pediculosis formed 23.4%, out of which one child had plica polonica (0.3%). Papulosquamous disorders like seborrheic dermatitis and scalp psoriasis formed 12.5% and 7.5%, respectively. Alopecia areata was seen in 7.9% and we had three cases of morphea (0.9%). Pigmentary disorders of the scalp seen were poliosis (0.9%) and presenile canities (3.48%). Nevoid conditions like nevus sebaceous were found in five children (1.5%) and we had one child of woolly hair nevus. There were five cases of trichotillomania (1.58%), one case of aplasia cutis (0.3%), two cases of ichthyosis with scarring alopecia (0.63%), and three infants with delayed telogen occipital alopecia (0.94%). **Conclusion**: In our study, we noted that bacterial infections of the scalp had the highest incidence. We present this study to highlight the varied spectrum of scalp and hair disorders seen in the pediatric age group.

O 31: Clinico-mycological Study of Tinea Capitis

Renu, Geetha K., Madhu R., Janaki C.

Department of Dermatology, Mycology Section, Madras Medical College, Chennai, India

**Background**: Tinea capitis is a superficial fungal infection of the scalp and scalp hair that is caused by dermatophytes belonging to the genera *Trichophyton* and *Microsporum* and is most common in children. The most common causative agent in South India is *Trichophyton violaceum*. **Aims and objectives**: To study the epidemiological aspects, to identify the various etiological agents, clinical types, to determine the clinico-etiological correlation of tinea capitis, and to note the changing trends. **Materials and Methods**: All new patients with tinea capitis who attended the outpatient department of our mycology section from June 2010 to October 2011 were included for the study after KOH positivity. Patients who had taken topical antifungal treatment 2 weeks before and systemic antifungal treatment 4 weeks before were excluded from the study. Finally, 98 patients in the age group ranging from 1 to 63 years were taken as the study group. Detailed history taking and clinical examination was done in all patients. Scalp scrapings and hair root samples were analyzed by KOH wet mount. KOH positive specimens were cultured on Sabouraud′s dextrose agar with and without actidione. **Results**: Tinea capitis occurred predominantly in children, more in boys compared to girls. Non-inflammatory types were more commonly observed, with gray patch being the most common type. Kerion was the most common type in the inflammatory group. The majority of the isolates were *Trichophyton surans* (31.1%), followed by *T. violaceum* and *Trichophyton mentagrophytes*, each in 25.7%. The clinico-mycological correlation reveals that a single agent may give rise to various clinical types. In the previous studies, *T. violaceum* was the most common agent isolated in South India, whereas *T. tonsurans* is the most common agent in this study, showing a changing scenario which has to be studied further in a larger group.

O 32: Clinical Patterns of Trichotillomania -- Case Series

Sahana M. S.

Bangalore, India

Trichotillomania is characterized by recurrent and persistent urge to pull out ones own body hair. It is seven times more common in children than in adults. It is more common form of artifactual disease after thumb or finger sucking. Trichotillomania presents in different clinical patterns. **Case 1**: A 13-year-old female child presented with pulling of hair on the scalp from 1 year. The child had patchy area of hair loss on crown area surrounded by rim of unaffected hair (Friar tuck sign). A diagnosis of tonsure trichotillomania was made. **Case 2**: A 4-year-old hyperactive male child presented with pulling of hair from the left side of scalp from 2 months. Examination revealed diffuse patches of alopecia in the right parietal region. **Case 3**: A 4-year-old female child had history of pulling of hairs from the occipital area from past 6 months. There was non-scarring focal patch of alopecia on the occipital area. None of the children had history of pulling hairs from other parts of the body. There was no history suggestive of trichophagia. A comprehensive psychiatric assessment was made in all cases. Trichotillomania in young children is a habit phenomenon that is not usually a sign of serious emotional disturbances. It is important to rule out other causes of alopecia in children like alopecia areata and tinea capitis to diagnose trichotillomania. We present these cases to highlight the varied clinical presentation of this hair pulling disorder. Among them, tonsure trichotillomania is the most typical pattern.

O 33: Hair Dye Dermatitis: Clinical Manifestations and Patch Testing Using Hair Dressing Series

Sindhu Potla

Mysore, India

**Aims and objectives**: Paraphenylenediamine (PPD), resorcinol, and other preservatives are used in hair dyes and cause hair dye dermatitis (HDD).They can be identified by patch testing with hair dressing series. Till date, in India, studies using hair dressing series to identify these allergens have not been reported. Our study aims to identify the various clinical manifestations, allergens, and their correlation using hair dressing series. **Materials and Methods**: A descriptive cross-sectional study was conducted from October 2011 to April 2012. All patients with suspected HDD were included. After detailed history and complete clinical examination, patch test was performed using hair dressing series and read after 48 and 96 h based on ICDRG guidelines. Statistical analysis was performed. **Results**: Fifty patients were included in the study. Seventeen were patch tested (12 males and 5 females). 80% females were in 41--50 year age group, but majority of males were above 50 years (41.7%). Duration of hair dye application was more than 1 year in majority of patients. Clinical symptoms varied from acute to chronic eczema. In ICDRG grading, doubtful reactions was noted with highest frequency followed by 1+ and 2+. Most frequently noted allergen was PPD; however, other allergens were also identified in hair dressing series which are not present in Indian standard series. In one case, angry back syndrome was noted. **Conclusion**: HDD is more common among young adult males. Hair dressing series is helpful to identify other allergens along with PPD. Clinical presentation and patch test results showed significant correlation.

O 34: Dermoscopic Study of Non-cicatricial and Cicatricial Alopecias

Nishant Ghodake

Pondicherry, India

**Aims and Objectives**: To study the dermoscopic findings in patients diagnosed with cicatricial and non-cicatricial alopecias. **Materials and Methods**: It is a descriptive study involving single group of patients attending the dermatology OPD with alopecia. Diagnosis was made clinically, and where needed, aided by additional tests including scalp biopsy. Heine delta 20 dermoscope was used for evaluation. **Results**: A total of 300 patients of cicatricial and non-cicatricial alopecias were enrolled for the study. The following types of alopecias were seen: alopecia areata (AA; 85), telogen effluvium (55), female androgenetic alopecia (FAGA; 10), androgenetic alopecia (64), tinea capitis (20), hair shaft disorders (8), discoid lupus erythematosus (DLE; 22), pseudopelade of Brocq (18), lichen planopilaris (LPP; 12), and others. The dermoscopic findings in AA were yellow dots (84%), black dots (67%), broken hairs (56%), short vellus hairs (42%), and tapering hair (14%). Tinea capitis showed "comma hairs" in 100% patients. Male as well as female androgenetic alopecia showed hair diameter variability of more than 20%. Hair follicle effacement was seen in 100% of patients with ciactricial alopecias. Dermoscopic findings in cicatricial alopecia were: DLE (hair follicle effacement, red dots, patchy deep pigmentation, hair follicle plugging), LPP (perifollicular scaling, erythema, white dots, hair follicle effacement), and folliculitis decalvans (tufting of hair, hair follicle effacement). Monilethrix showed typical beading of hair. In AA, severity of disease correlated with number of yellow dots, black dots, and tapering hair. **Conclusion**: Dermoscopic findings are typical in several alopecias and correlate well with clinical/histopathologic diagnosis.

O 35: Detection of Polycystic Ovarian Syndrome Using a Minimal Battery of Tests in Patients of Female Pattern Alopecia

Behroze M. Deputy

Mumbai, India

**Background**: Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorders affecting 5--10% women and is one of the leading causes of female pattern alopecia (FPA). Other features are obesity, irregular menstruation, and excessive amounts of androgenic hormones resulting in hirsutism and acne. **Aim**: To investigate patients of FPA for underlying PCOS by doing an ultrasonography of the ovaries and minimal hormonal tests. **Materials and Methods**: Forty female patients with different grades of FPA, clinically suspected to have PCOS, were enrolled. Only dihydrotestosterone (DHT), free testosterone, serum insulin levels, thyroid test, complete blood count, and ultrasonography of the ovaries were done. **Results**: Increased levels of the following were observed in patients: DHT (25), free testosterone (15), serum prolactin (3), serum insulin (22), and thyroid hormone (7). Twenty-five patients showed PCOS pattern on ultrasonography. Six patients showed normal investigations but clinically pointed toward PCOS. Patients were treated with OC pill with anti-androgenic drug, metformin, and multivitamins, along with topical therapy. The hair fall stopped in 90% of the patients, though new hair growth was seen only in 15% patients. Some patients were also started on flutamide and other treatments like growth factors, platelet-rich plasma with dermaroller, and were followed up for 1 year. Therefore, the battery of minimum required tests could confirm the diagnosis of PCOS in most suspected cases. **Conclusion**: The above battery of tests for diagnosing PCOS was found to be positive in 85% of patients with FPA and was economical.

O 36: Non-anemic Iron Deficiency in Men with Pattern Hair Loss -- Retrospective Analysis

Santhanalakshmi T.

Chennai, India

**Background**: All men are not iron men! Iron deficiency is more commonly noted among women and it is generally taken for granted that males have normal iron levels. But we have something different to put forward after our observation from our study. **Aim**: The aim of our study was to note the frequency of low ferritin level in males who presented with androgenetic alopecia. **Materials and Methods**: It was a retrospective analytical study of patients who presented to us with androgenetic alopecia, aged from 16 to 55 years. **Results**: Of the 800 patients reviewed, 485 were males. They presented with different grades of Hamilton scale AGA, the most common of which was Grade-IVa. 40% (194 patients) of our study population had low ferritin levels. We considered a value of less than 70 ng/ml as low, although the normal range for males is between 22 and 322 ng/ml. This is because ferritin level needs to be maintained above 70 in order to attain a good response from minoxidil. The most common association noted among our patients was hypothyroidism. **Conclusion**: Thus, the findings of our study were quite surprising and showed that non-anemic iron deficiency exists in a significant number of men with male pattern hair loss (MPHL). So, our paper stresses the importance of ferritin assessment in MPHL and its replacement in deficient cases in order to get the desired therapeutic response.

O 37: "HO-VER"ing over Alopecia Areata -- A Histopathologic Study of 50 Cases of Alopecia Areata

Manjot Marwah

Navi Mumbai, India

**Objectives**: There are many studies done on the histopathology of alopecia areata (AA) in horizontal and vertical sections. All these studies do mention that horizontal sections are more diagnostic; however, very few of them mention that multiple sections are required to count the anagen:telogen ratio. This mainly depends on the level of the horizontal section, since telogen is diagnosed only when we have a section showing the telogen hair bulb. We have studied the specificity of the histopathologic findings in AA in 50 patients, 25 with single vertical sections and 25 with single horizontal sections. **Materials and Methods**: A prospective and retrospective study of H and E sections of 50 patients clinically diagnosed as AA in 2 years (2010--2012) was conducted. **Results**: Low follicular count was the commonest feature in horizontal sections with a higher specificity, compared to peribulbar infiltrate, which was the commonest finding in vertical sections. Also, a single horizontal section showed ratio of non-telogen:telogen hair rather than anagen:telogen. This ratio also has a high specificity for diagnosis of AA. **Conclusion**: Not all cases show peribulbar lymphocytic infiltrate; hence, such cases can be diagnosed only with a horizontal section, by showing low follicular count and non-telogen:telogen hair ratio. Hence, a single horizontal section of 4 mm hair biopsy sample is sufficient to aid the diagnosis and prognosis of AA. The dilemma of "HOR"izontal versus "VER"tical sectioning in the diagnosis of AA requires further studies.

O 38: Keratosis Pilaris -- Revisited: Dermoscopic Observations and Retrospective Review of Skin Biopsies

Mary Thomas

Mumbai, India

**Background**: Keratosis pilaris (KP) is characterized by keratinous plugs in the follicular orifices and varying degrees of perifollicular erythema. The most accepted theory of its pathogenesis proposes defective keratinization of the follicular epithelium resulting in a keratotic infundibular plug. We decided to test this hypothesis by doing dermoscopy and reviewing biopsies of patients diagnosed clinically as KP. **Materials and Methods**: This study was conducted in two parts. Patients with a clinical diagnosis of KP seen between September 2011 and December 2011 were included in the study. A clinical history was obtained, and examination and dermoscopic evaluation were performed on the lesions of KP. Skin biopsies done during the last 1 year (January 2011--December 2011) with a clinical diagnosis of KP were reviewed in the light of these observations to look for any infundibular plugs. Histopathologic findings were summarized and analyzed. **Results**: The age of patients who underwent dermoscopy ranged from 6 to 38 years. All the 25 patients were found to have coiled hair shafts within the affected follicular infundibula. Perifollicular erythema was seen in 11 patients and perifollicular scaling in 9. Twenty-eight biopsies of KP over 1 year were reviewed retrospectively. Even after doing deeper cuts for demonstrating infundibular plugging, such plugs within dilated infundibula were found only in 5 (17.8%) cases. In majority (21.75%) of the cases, the involved follicle only showed mild fibrosing perifolliculitis. In 2 (7.14%) cases, there were no histological abnormalities seen. **Conclusion**: From our observations we infer that KP may not be a keratinization disorder, but is caused by the circular hair shaft which ruptures the follicular epithelium leading to inflammation and abnormal follicular keratinization.

Best on the Bedside -- Trichoscopy: O 39 Trichoscopy as a Tool in Pattern Hair Loss

Ralph M. Trüeb

Zurich-Wallisellen, Switzerland

Dermoscopy is a non-invasive diagnostic tool that permits recognition of morphologic structures not visible to the naked eye. Dermatologists involved in the management of scalp disorders have discovered dermoscopy to be also useful in their daily clinical practice. Scalp dermoscopy or trichoscopy is not only helpful for the diagnosis of hair and scalp disorders, but also gives clues about the disease stage and progression. Structures which may be visualized by trichoscopy include hair shafts of different types (vellus, terminal, intermediate, pathologic), follicular patterns (white, yellow, and black dots), vascular patterns, abnormalities of pigmentation, scaling, and exogenous materials. Using trichoscopy, signature patterns are seen in a range of scalp and hair conditions. Trichoscopic features of pattern hair loss (PHL) are diversity of hair shaft diameter, peripilar sign, and empty follicles; additional findings may be honeycomb pigment pattern and arborizing red lines. Among the methods for diagnosis of PHL, the trichogram reflects low-grade telogen effluvium of the affected frontal and centroparietal scalp, while the trichoscopic finding of anisotrichosis relates to the presence of hairs with different caliber as a consequence of progressive hair follicle miniaturization. Originally Tosti *et al*. suggested that diversity of hair shaft diameter \>20% is diagnostic of PHL. More recently, Rakowska *et al*. proposed more sophisticated diagnostic criteria for diagnosis of PHL in women based on trichoscopic imaging. Major criteria are: (1) ratio of more than four empty follicles in four images (at 70-fold magnification) in the frontal area, (2) lower average thickness in the frontal area compared to the occiput, and (3) more than 10% of thin hairs (\<0.03 mm in diameter) in the frontal area. Minor criteria were: (1) increased frontal to occipital ratio of single-hair pilosebaceous units, (2) vellus hairs, and (3) peripilar signs. Fulfillment of two major criteria or of one major and two minor criteria allows diagnosis of PHL in women with 98% specificity. We performed a study to evaluate the value of trichoscopy as compared to the trichogram for the diagnosis of PHL in women and found that trichoscopy is a valuable and superior method to the trichogram for diagnosis of PHL in women, especially in early cases, with the highest yield irrespective of the suggested cut-off of 20% diversity of hair shaft. Presence of peripilar signs might point to perifollicular microinflammation and fibrosis, rendering PHL less responsive to standard treatment, while presence of honeycomb pigment pattern and arborizing red lines relates to the extent of UVR exposure and possibly damage. Ultimately, examination of the scalp by dermoscopy can reassure patients with PHL that they have received a thorough scalp examination, since patients with hair loss are very distressed and often feel that they are not properly examined.

**Further Reading**

Galliker NA, Trüeb RM. Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia. Int J Trichology. 2012 Jan;4(1):19-22.

O 40: Trichoscopy in the Pigmented Scalp and Scarring Alopecia

Antonella Tosti

Miami, USA

Trichoscopy of pigmented scalp is scarcely reported. The most important characteristic is the presence of interfollicular pinpoint white dots. These can be seen in the sun-exposed scalp of phototypes III and IV and in the normal scalp of V and VI. They appear as small (0.2--0.3 mm) white dots distributed regularly in the interfollicular scalp, dispersed among the mosaic pigmented network. They correspond to both sweat ducts and follicular openings. Distinguishing scarring from non-scarring alopecia is therefore often difficult as the loss of follicular openings is not so evident. This presentation reviews the normal characteristics of black scalp and the dermoscopic features of most common disorders observed in African Americans, including tinea capitis, central centrifugal cicatricial alopecia, and traction alopecia.

O 41: Trichoscopy of Scarring Alopecia

Antonella Tosti

Miami, USA

Dermoscopy of both primary and secondary types of scarring alopecia is characterized by decreased hair density and loss of follicular openings. The latter is easily appreciated in non-pigmented scalp but is very difficult to evaluate in the dark scalp, where it is impossible to distinguish follicular openings from acrosyringeal openings as they all appear as white dots. The only exception is discoid lupus erythematosus (DLE) where white dots disappear because the inflammation also affects the adnexal structures. The dermoscopic and pathologic features of frontal fibrosing alopecia (FFA) and LPP are indistinguishable and include absence of follicular openings, cicatricial white patches, peripilar casts, blue-gray dots, and in addition perifollicular erythema in FFA. Specific features for DLE include keratotic plugs, red dots, and enlarged branching vessels. Characteristic dermoscopic findings include tufted hairs which are observed in advanced cases and typically include six or more hairs emerging from the same ostia.

O 42: Conventional Grading Classifications or Dermatoscopy for Early Diagnosis of Female Pattern Hair loss?

Sukesh M.S., Rachita Dhurat

LTM Medical College, Mumbai, India

**Background**: The clinical diagnosis of female pattern hair loss (FPHL) according to the Conventional Grading Classifications is based mainly on thinning and clinical widening over mid-scalp. However, FPHL could be a diffuse process, which may present without patterned hair loss. Of late, hair diameter diversity (HDD) \>20% on dermoscopy provides a valuable tool in assessing the miniaturization process, characteristic of FPHL. **Aims**: To assess whether conventional classification or dermoscopy is useful for early diagnosis of FPHL and also to document apparent sparseness of hair as per Conventional Classification and HDD on dermoscopy (10×), separately at standard scalp sites of the scalp to prove the non-patterned nature of FPHL. **Materials and Methods**: Fifty-two Indian females complaining of increased shedding of hair of more than 6 months duration with either Grade II of WASS Classification or Grade I of WASS Classification (normal mid-parting), but with positive hair diameter diversity present anywhere on the scalp were enrolled. Clinical sparseness and HDD on dermoscopy were assessed separately at mid-scalp (MS), bi-frontal (BF), temporal (T), and occipital (O) areas at specific sites. HDD \>20% at the above sites was considered to be a diagnostic sign of FPHL. **Results**: Dermoscopy could detect 42% (22/52) more cases which were undiagnosed on clinical assessment based on conventional grading scales (Grade 1). Dermoscopy could also detect miniaturization in other areas, along with mid-scalp involvement. Also, 15% cases showed clinical sparseness/positive HDD exclusively in areas other than mid-scalp. **Conclusion**: Dermoscopy serves as a valuable tool to detect the miniaturization process in early FPHL and in non-patterned cases, which could be missed through Conventional Grading Classifications. Hence, it should be offered as a routine diagnostic procedure and the entire scalp has to be assessed for miniaturization, in women presenting without obvious clinical sparseness.

O 43: "Question Mark Hair": A New Trichoscopic Finding in Trichotillomania

Shekhar Haldar

Mumbai, India

Trichotillomania is a compulsive disorder characterized by an irresistible urge to pull one\'s own hair followed by a sense of relief once the act is done. It mostly affects preschool children and adolescents, majority being females. The vertex is the most common site of involvement. Other sites that can be involved are the eyebrows, eyelashes, and pubic areas. We encountered such a case where an adolescent girl presented with complaints of patchy alopecia over both the eyebrows. Alopecia areata was a more likely possibility as compared to trichotillomania. However, trichoscopic examination revealed black dots, broken hair shafts, variable length of the fractured hair shafts, absence of any yellow dots, exclamation hair, and depigmented vellus hair. These features were consistent with a diagnosis of trichotillomania. In addition, we encountered some new trichoscopic findings that have not been previously described in a case of trichotillomania. "Question mark hair" and "reverse exclamation hair" are some of the new findings that we think are worth presenting.

Tricho Immunology: O 44 An Update on Alopecia Areata

Desmond J. Tobin

Great Britain, UK

Much of the recent progress on alopecia areata (AA) has emerged from studies on the well-characterized C3H/HeJ mouse, which has provided useful data not only on the complex genetics of AA, but also on its associated immune perturbations and assessment of various treatment modalities. Other advances over the last few years have been in there areas of AA genetics, hair follicle autoantigen identification, and so-called collapse of "immune privilege" in the lower anagen hair follicle. Our lab has recently identified the inner root sheath protein, trichohyalin, as a potential target antigen in AA. Christiano\'s group searched for AA-associated genes in over 1000 patients and found several variations. Thus, in immunogenetically predisposed individuals, the hair follicle may be attacked by an immune system where anagen hair follicle-associated antigens lose their former immuno-privilege are now instead targeted by a full-blown anti-hair follicle immune response. There is no cure for AA, and still no FDA-approved medications. The management of AA varies considerably between practitioners, and there remains a paucity of randomized, placebo-controlled trials for AA treatments. Despite this, a broad range of treatment modalities can be used, including topical, systemic, and intralesional corticosteroids; topical immunotherapy; topical minoxidil; anthralin; and psoralen plus ultraviolet. Contact sensitizing agents have proven effective for extensive cases of AA. Also, despite much hope, the use of biologics from the psoriasis field has unfortunately proven unsuccessful in AA.

O 45: Update on Topical Immunotherapy in Alopecia Areata

Kumaresh M.

Coimbatore, India

Alopecia Areata (AA) is a common non-scarring alopecia and modalities have been tried for the treatment of severe AA. Dinitrochlorobenzene (DNCB), squaric acid dibutylester (SADBE), and diphencyprone (DPCP) are the contact allergens used. Topical immunotherapy is defined as the induction and periodic elicitation of allergic contact dermatitis (ACD) by applying a potent contact allergen. DNCB has been found to be mutagenic by the Ames test and genotoxic by the sister chromosomal exchange in human fibroblasts. Although no evidence of carcinogenicity is reported in patients treated with DNCB, it has been largely replaced by DPCP and SADBE. SADBE is unstable in acetone and requires special solvents and additives to maintain potency because of its tendency to undergo hydrolysis. DPCP is commonly used in severe and refractory AA. The process of procuring, dilution, and application limits the use of topical immunomodulators. Efficacy of topical immunomodulators varies from 4 to 85%. The common adverse effects after DPCP applications are local eczema with blistering, regional lymphadenopathy, and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmentation, hypopigmentation, and vitiligo. Despite the difficulty in procuring, dilution, application, and prolonged treatment schedule, topical immunomodulators still remain the best documented treatment in severe and refractory AA.

O 46: Dramatic Results of DPCP Immunotherapy

Murugusundram S.

Chennai, India

**Background**: Diphencyprone (DPCP) immunotherapy is an oasis in the desert of therapies for alopecia areata (AA). The results are dramatic and gratifying, especially in alopecia totalis and universalis. **Materials and Methods**: We present our experience of DPCP in nine patients of whom seven had alopecia universalis (AU) and two had multiple AA. DPCP was applied in increasing concentrations every fortnight from 0.001%, 0.01%, 0.1%, 0.2%, and so on, up to 1%, after the initial sensitization with 2%. **Results**: Three out of seven AU patients showed complete hair growth with spontaneous regrowth of facial and body hair in one. Out of the remaining four, three showed partial regrowth and one showed regrowth of only vellus hairs. Both the multiple AA patients, including ophiasis in one, showed complete regrowth. All the patients started showing response after an average of six applications. All of them had severe itching which was controlled by oral antihistamines. Two patients had transient hypopigmentation and hyperpigmentation. **Conclusion**: DPCP is definitely a boon for badly affected AA patients.

Liquid Nitrogen Cryotherapy -- A Promising Tool in Treatment-resistant Alopecia Areata

Murugusundram S.

Chennai, India

Old is always gold. Cryotherapy is an old method of dermatotherapy with multiple benefits. Liquid nitrogen (LN2) cryotherapy is also a form of topical immunotherapy which is well tolerated and yields desirable results in alopecia areata (AA). We present 20 resistant cases of AA which did not respond to even topical diphencyprone (DPCP) immunotherapy, treated successfully LN2 cryotherapy. Extensive AA with multiple discrete patches, reticulate pattern, alopecia ophiasis, alopecia totalis, and alopecia universalis responds very poorly to all forms of available therapy. Few cases fail to respond to topical DPCP immune therapy also. These cases were given LN2 cryotherapy using the Cryo spray gun. The Cryo gun was held at least 15 cm away from the affected area of the scalp and LN2 was sprayed like a paint spray in quick circular motion. The freezing time was very short (less than 20 seconds per area). Severe pain was experienced during the procedure by some, but it quickly subsided within few minutes. No major post-procedural discomfort or complications were observed. All the cases responded very well by showing complete hair growth. Surprisingly, most of them grew dark hairs. Transient hypopigmentation at the treatment site was seen in few cases, which spontaneously re-pigmented. LN2 cryotherapy is an easily available, inexpensive, well-tolerated, non-steroidal, safe immune-modulatory therapy which can also be claimed to reduce recurrent rates. We would like to recommend Cryo as a first-line therapy in extensive AA.

O 47: Treatment of Extensive Alopecia Areata with Phenol and Targeted Phototherapy

Chandrashekhar Purandare

Kolhapur, India

**Background**: Alopecia areata (AA) is an autoimmune disorder, usually self-limiting. However, a small percentage of the patients do not achieve the remission and are very difficult to manage, particularly, phenolization and narrowband UVB are two of the treatment modalities used with variable success in literature. We have tried to treat patients of extensive and refractory AA with the help of alternating cycles of these two modalities. **Materials and Methods**: Number of patients was six (four females and two males) in the age group of 15---35 years. All other causes of alopecia were excluded with. The lesions were present for more than 2 years. Extent of lesions: Scalp (with ophiasis), eyebrows, eyelashes, beard area. Treatment received in past: Oral and topical steroids, immune modulators, finasteride, minoxidil. Treatment given: Alternate cycles of phenolization (88%) till frosting appeared. **Results**: Four patients showed good improvement (\>50%) at the end of 8 months, while two patients continued to be resistant to treatment. **Conclusion**: Phenolization and narrowband UVB have been used singly with variable success in the management of AA. The mechanisms of action of these two are different and we have tried to synergize them together. As more and more studies come up in future, the outcome of resistant AA could certainly improve.

O 48: DPCP -- Our Experience

Somshukla Ray

Mumbai, India

**Background**: To study the efficacy and adverse effect profile of diphenylcyclopropenone (DPCP) in patients with alopecia areata. **Materials and Methods**: Eight patients of both sexes and varied age groups with alopecia areata were treated with one application of DPCP per week. The patients were evaluated weekly for evidence of new hair in the alopecic patch. The color and type of hair were also noted. Examination was also done for appearance of new patches or any adverse effect of DPCP. **Results**: The earliest evidence of hair growth was by 5^th^ week. Improvement was noticed in most patients with a short duration of the disease (few months). However, patients with disease resistant to different modalities of treatment for years showed little improvement, if any. The major adverse effects noted were generalized itch and urticaria in 2/8 patients that resolved on withholding the drug. One of them also developed hypopigmented and depigmented patches on scalp at 4^th^ month of application, following which DPCP was stopped. **Conclusion**: We hereby aim to share our experience with DPCP in alopecia areata and to highlight the high incidence of adverse effects of the drug. Larger well-controlled trials and careful monitoring of patients are necessary to establish the safety and efficacy of DPCP.

O 49: 308-nm Excimer Light in Alopecia Areata

Satish Udare

Navi Mumbai, India

**Background**: The treatment of alopecia is varied, and also the outcomes. Treatment ranges from administering local steroids, tacrolimus, and minoxidil to systemic therapies with steroid antimetabolites. Considering the effectiveness of these and the effect on vitiligo, it was thought excimer light may be useful in alopecia areata. **Objective**: To assess the efficacy and safety of excimer light for the treatment of alopecia areata. **Materials and Methods**: Twenty patients with alopecia areata on the scalp and beard were treated by excimer light two times a week until they achieved hair growth or for a maximum of 20 treatment sessions. They were assessed visually by comparing photographs taken before and at the end of treatment and by independent observer\'s assessment. **Results**: Ten patients showed complete regrowth and eight showed 80% hair growth. Two patients were lost to follow-up. The average number of sessions ranged from 7 to 12. The study is limited by the small number of patients. There were minimal side effects, which included slight hyperpigmentation which patients did not mind, and two patients developed erythema with pain. **Conclusion**: Treatment with the 308-nm excimer light may be effective for alopecia areata located on the scalp.

Genes Matter: O 50 Clinical Aspects of Genetic Hair Disease

Andrew G. Messenger

Sheffield, UK

Hair disorders due to single gene mutations are rare, but there are many of them and most dermatologists will encounter them from time to time. Broadly speaking, genetic disorders can be classified into disorders of hair follicle development, of hair cycle control, and structural anomalies. There is increasing knowledge of the gene mutations responsible, but in many cases, less is known about how the genotype translates into the clinical phenotype. However, it is apparent that similar clinical features may be seen with mutations in different gene. This is important because some genetic hair disorders have significant systemic implications despite a similar trichologic presentation to those that do not. These issues will be discussed along with clinical examples.

O 51: IFAP Syndrome in Females: A Rare Entity

Meeta Mantri

Mumbai, India

IFAP syndrome is an extremely rare genetic syndrome characterized by widespread spiny keratotic follicular papules, severe photophobia, and generalized non-scarring alopecia of early onset involving the scalp, eyelashes, eyebrows, and body hair. Other findings include delayed. growth and development, seizures, increased susceptibility to respiratory infections, and signs of atopy. Most cases are X-linked recessive. Apart from classical X-linked form, there is another type where females are partially affected and one other type where females have full IFAP symptoms. Females usually have mild affection with presence of few features. **Case 1**: A 9-year-old girl born from a non-consanguineous marriage presented with complaints of rough skin over the scalp and body since 5 years, and partial loss of scalp and eyebrow hair. She gave no history of photophobia. Physical examination revealed multiple keratotic follicular skin-colored horny papules over the scalp, eyebrows, cheeks, and body, and areas of non-scarring alopecia, loss of the lateral half of eyebrows and scalp. Ophthalmic examination revealed squamous blepharitis. **Case 2**: A 10-year-old girl born from a third-degree consanguineous marriage presented with hair loss from scalp and eyebrow since birth and spiny lesions over the body since 8 years. She gave history of photophobia. Cutaneous examination revealed areas of non-scarring alopecia with diffuse thinning and loss of eyebrows and eyelashes, and multiple keratotic follicular skin-colored papules giving "sand papery texture" to skin all over the body. Skin biopsy from body lesions of both cases showed dilated follicular infundibulum with follicular plugging and biopsies from scalp revealed no evidence of scarring alopecia. Thus, we report two cases of IFAP syndrome which is a rare entity, especially in females.

O 52: Atrichia with Papular Lesions

Rajesh R.

Erode, India

Congenital atrichia with papules (APL) is a unique autosomal recessively inherited disorder characterized by the presence of universal irreversible alopecia and disseminated papular lesions. It is considered to be human analog of hairless mouse. Here we report one such rare case. A 4-year-old female child born to third-degree consanguineous parents presented with total loss of scalp hair. Patient was born with normal hair which shed within few months of life and had never regrown since then. General and systemic examination was normal. Dermatological examination revealed multiple follicular keratotic papules over the scalp and few in neck and extremities. Few vellus hairs were present over the scalp. Teeth, nail, and available mucosa were normal. Routine investigations were within normal limits. Skin biopsy was done and histopathology was correlating. Topical retinoic acid cream application at bed time was initiated as therapeutic trial. Wig was advised as cosmetic camouflage. Dr. Angela Christino demonstrated mutation in the zinc finger of hairless gene in chromosome 8p12 in patients with APL. So far, less than 50 cases have been reported in the world literature. We report this rare case because of negative family history and to highlight the fact that there are no therapeutic options.

Tricho Pathology: O 53 Trichoscopy-guided Hair Biopsies

Antonella Tosti

Miami, USA

Scalp biopsies are crucial for the diagnosis of cicatricial alopecia. However, the pathologic interpretation may not be diagnostic if biopsy is not obtained from the correct site. This is particularly relevant for cicatricial alopecia as the disease may be focal and disease activity is difficult to appreciate by the naked eye. In the last 2 years, we performed dermoscopy-guided scalp biopsies using handled dermatoscopes in 80 patients with different forms of cicatricial alopecia. Biopsy site was selected based on presence of the following dermatoscopic features: perifollicular concentric white scales in lichen planopilaris, frontal fibrosing alopecia (FFA), and discoid lupus erythematosus (DLE); hair tufts in folliculitis decalvans, hairs surrounded by a peripilar gray-white halo in central centrifugal cicatricial alopecia, and follicular red dots or keratotic plugs in DLE. The dermoscopy-guided biopsies yielded a definitive pathological diagnosis in 95% of the cases. The advantage of this method is that it is a fast, precise way to identify even individually affected follicles in early or focal cicatricial alopecia. It also allows for the morphologic characterization of particular follicular structures.

O 54: Essentials of Trichopathology for an Emerging Dermato-trichologist

Punit Saraogi

Mumbai, India

Most of the dermatologists shy away from performing a scalp biopsy. And when they do, they fail to obtain essential meaningful information out of the same. Scalp biopsies are indicated in all cases of cicatricial alopecias and in all cases of unexplained non-cicatricial alopecias. An organized diagnostic and management strategy will help both to identify the cause of alopecia and to direct therapy.

Essentials of trichopathology for the emerging dermato-trichologist are:

Understanding when to perform a scalp biopsyHow to choose the best site to yield maximum resultsHow to send biopsies for histopathologic sectioningNormal anatomy and architecture of hair and scalp in horizontal and vertical sectioningKey histological features of diseasesClinicopathologic correlation

O 55: Extracting Information from Horizontal Sections

Uday Khopkar

Mumbai, India

Horizontal sections for scalp biopsy have been practiced occasionally to reach exacting clinicopathologic diagnosis of alopecias. However, their routine use is fraught with difficulties. We have been using horizontal sections for diagnosis of diffuse alopecias in women in search of results. Horizontal sections done at the level of infundibulum allow one to calculate terminal vellus ratios and "sebaceous index." Sections done at the level of upper stem allow one to calculate telogen anagen ratio and look for inflammatory infiltrate and fibroplasia. Lowermost sections done at the level of lower stem allow one to calculate follicles that have gone into telogen but have left behind follicular stellae and can therefore regrow with therapy. Horizontal sections thus allow us to differentiate between androgenetic alopecia and chronic telogen effluvium, as well as inform us about the scalp condition including inflammation, fibroplasias, and readiness for transplant.

Microbes and Mycoses: O 56 Multi-mechanistic Approach for Seborrhea and Alopecia

Alain Khaiat

Singapore

Using seborrhea as an example, we will show how understanding the biological mechanism behind the problem can lead to innovative and more effective solutions. Seborrhea is an increase of sebum secretion, leading to excess sebum excretion. The end result for the consumer is shiny skin or hair and often irritation. How can this be reversed for an equilibrated secretion? How can the learning be adapted to alopecia?

O 57: Dandruff -- Current Status

Frederick Manuel

Chennai, India

Dandruff and seborrheic dermatitis are common chronic relapsing scalp skin diseases affecting about half of the postpubertal population. Scientific observations have linked both diseases with the yeast Malassezia. A localized inflammatory response is formed against Malassezia yeasts residing on the skin. Removing the organisms with an antifungal medication leads to remission of both diseases. The exact pathogenetic mechanisms involved in both are not clear. It is possible that one problem common to both dandruff and seborrheic dermatitis is that yeast genes are switched on to produce different metabolites on both dandruff and seborrheic dermatitis-affected skin. The metabolite oleic acid could explain the histological and ultrastructural changes seen in dandruff. In seborrheic dermatitis, metabolites such as malassezin with immunoregulatory functions are produced in lesions of seborrheic dermatitis. This may activate an inflammatory pathway leading to the typical clinical signs of the condition.

O 58: Therapeutic Response to Systemic Antifungal Agents in Tinea Capitis

Remya Raj

Chennai, India

**Background**: Tinea capitis is the most common dermatophytosis seen in children. Griseofulvin has been the gold standard treatment in children with tinea capitis. Newer systemic antifungal agents with good safety profile are available at present. **Aims and Objectives**: To observe the therapeutic response of patients with tinea capitis to griseofulvin, ketoconazole, and newer antifungal agents, namely fluconazole, itraconazole, and terbinafine, and to study the merits and demerits of the above-mentioned drugs. **Materials and Methods**: Fifty patients with clinical and mycologically confirmed tinea capitis, of age up to 18 years, were randomly selected and divided into five groups with 10 in each group. Each group was administered one of the five antifungal agents in the standard specific dose for specific duration. Investigations like complete hemogram, liver and renal function tests were done before and after the therapy. "Cure" referred to complete clinical and mycological clearance at the end of the treatment. All the patients were monitored for the side effects during the period of treatment. **Results**: Clinical response was good in all the five groups; however, defaulter rate was more in the first two groups, viz. griseofulvin and ketoconazole. In the itraconazole group, one child with *Trichophyton simii* infection who failed to respond was started on griseofulvin with complete cure. No hematological or biochemical abnormalities were observed at the end of the treatment. Conclusion: All five drugs appear relatively safe. No adverse effects were observed with any of the drugs. Newer antifungal agents have an advantage of shorter duration and single daily dose therapy, but there is a constraint of high cost. Terbinafine is cost effective when compared to the other two agents.

Tricho Surgery: O 59 Why Choose HT in your Practice? & How to Set-up a New HT Center?

Mysore Venkatram

Bangalore, India

O 60: Anaesthesia: Blocks, Local Infiltration, Role of sedative Yes/No

Indu Sattur

Mumbai, India

O 61: Harvesting with FUE

Aman Dua

Ludhiana, India

O 62: Harvesting with Strip

Sandeep Sattur

Mumbai, India

O 63: Balanced View, Pros and cons of FUT/ FUE

Sanjiv Vasa

Ahmedabad, India

O 64: Separation and Role of Magnification

Narendra Patwardhan

Pune, India

O 65: Plantation by Slit and Place

Manoj Khanna

Kolkatta, India

O 66: Plantation by Transplanter

Sanjiv Vasa

Ahmedabad, India

**Introduction**: In all the plantation techniques basic steps of the procedure include creating the ideal recipient site, keeping the site open and placement of graft into the cavity. Demand of meticulous plantation of hundreds of small delicate grafts in short time maintaining its integrity has been a real challenge. Many devices and methods for plantation have been used. In spite of all efforts they are not free from mechanical damage to the vital cells while holding, grabbing, pinching, dragging and pushing. Trying to insert graft into cavity can also produce crushing, squeezing, folding, distorting, jamming, distracting, bending and drying of grafts. **Objective**: The purpose of this study is to overcome as many problems as possible achieving plantation in one go at desired angle, direction, orientation and close proximity with higher speed maintaining integrity of grafts producing most natural results. **Materials and Methods**: A surgical device comprises of Handle/shield and Transplanter assembly. The Transplanter assembly is comprised of transplanter, stopper and hub. The transplanter is made up of body, piercing end, loading slot and neck. It is light weight, small, disposable (Single patient use), available in varying size to accommodate different size grafts having longer life span allowing more grafts plantation with only one device without any maintenance. It has a quite operating without use of electricity, suction and spring assistance having minimum joints and moving parts. The transplanter assembly is taken out of shield and fixed over one of its end to be used as a handle. Snugly fitting suitable size graft held by extra-cuticular hair is inserted into the transplanter either through loading slot or piercing end in the neck area. The transplanter is taken to the selected site over the skin and then skin is pierced at desired angle and direction in rotating fashion up to the stopper. Under direct vision with the slider the graft is placed inside the cavity till bulb touches the bottom of cavity. The transplanter is withdrawn holding the graft in place by slider leaving the graft firmly implanted in the skin. One is able to perform faster with easy maneuvering without requiring cleaning, removal of plugs or changing parts. Graft integrity is preserved during transfer, loading and plantation. Less time being wasted in arranging, separating and counting of grafts with creating, matching and counting recipient sites. It also allows the performer to be in total control of selecting site, angle, direction and spacing of grafts. **Results**: The device and the method have been used for more than a decade. It has been successfully tried in clients exceeding four figure numbers. It can be used to plant any size of grafts (chubby to very thin), for any ethnic shaped or textured hair, for any parts or surface of the body including scar tissue, in slit and place or all slit first and then plantation techniques, with less number of assistants (but more would definitely increase the speed). **Conclusion**: The instrument has significant benefit over the traditional instruments and techniques. The improved device provides incisor, stopper, rotator, opener, separator and slider all in one. Learning curve is simple and fast for novice.

O 67: FUE Hair Transplant in Female Pattern Hair Loss

Aman Dua

Ludhiana, India

FUE Hair Transplant is the latest and minimally invasive technique of hair restoration. It has gained popularity because it is stitch less and does not involve any linear scar. Hair transplant in females is the last resort for hair restoration because of scare of surgery and scarring in the scalp. FUE has overcome the limitations. **Materials and Methods**: 27 female patients over 1year were undertaken for FUE Hair transplant. Patients were selected randomly and belonged to Ludwig\'s grade 2 and 3. All of them underwent FUE as per surgery protocol like trimming hair, back bandages etc. All of them were given a questionnaire to be filled at the end of surgery as per following: any concerns regarding trimming, discomfort during the surgery, post op complications. Individual records were maintained on number of grafts, total number of hair per case, time taken for each hundred, follicular transection rate (complete and partial), area to be implanted, density given. Follow ups were done at 4, 6 and 12 months. **Results**: we found that all the patients were comfortable throughout the study, none complained of any major pain or discomfort. 13 females were conscious regarding trimming at back but were satisfied after 2 weeks with regrowth, none of the patients had any major post operative complication , 2 had folliculitis at donor area 2 weeks post op. Average number of grafts given were 1000, with average hair per follicle being 1.9, the follicular transection rate was 5 on average( we used 0.8mm punch), frontal area was mostly transplanted( 20) followed by temporal in 3 and both frontal and temporal in 2 and lowering of frontal hairline in 2. We gave an average density of 40 follicular units per cm2. Follow ups at 4, 6 and 12 months showed satisfactory growth and good results. **Conclusion**: FUE Hair transplant is a viable option for hair restoration in female pattern hair loss as it is cosmetically acceptable and overcomes the scare of typical surgery.

O 68: Follicular Unit Extraction in a Clinic Setup for Young Dermatologists

Avitus John Raakesh Prasad

Madurai, India

Hair transplantation has evolved from using 4mm Punch Hair Transplant by Dr. Orentreich in 1950s to Follicular Unit Hair Transplant (FUT) strip technique of 1990s and now the very recent Follicular Unit Extraction (FUE) technique has come close to the dream of 'no visible scarring' in the donor area is now looking like a possibility. This technique involves just three to four member team including the doctor. It can be done in a 60 -75 sq feet OT with very minimum instrumentation. In FUE, the grafts are extracted as individual follicular whereas the method of implantation remains the same as in the traditional FUT. This procedure can be done for areas other than scalp. It can be done for brow & mustache hair density abnormalities caused by trauma, burns, dermatological conditions & for cosmetic reshaping. This presentation reviews the methodology, limitations and advantages of FUE hair transplant. It also deals with how to successfully do a FUE hair transplant in a step by step process avoiding pitfalls, Tips and tricks to encourage the young dermatologists to feel confident in doing the procedure.

O 69: Learning Curve in FUE

Kuldeep Saxena

India

**Introduction**: Major issue in follicular unit extraction (FUE) technique is transaction of grafts. Every portion of follicular units are visible to operators in Follicular unit transplant (FUT), but FUE is a blind procedure. Even slightest amount of mistake can produce transected grafts. Transection is termed as any microscopically visible disruption of any portion of the hair follicles. **Purpose**: Our Two and half years long investigation was designed to explore potential factors responsible for follicular units transection and their management. Over the course of 300 consecutive cases impact of angle of hair, density, hair type, skin colour and depth variation in the donor area of each cases observed. Our purpose is to find out why some cases are much more difficult in terms of transection. **Materials and Methods**: A powered FUE device and Automated FUE device utilizing 0.75mm, 0.8mm and 1mm diameter were used for dissecting grafts. Each removed individual hair follicles were studied under 3x magnification and photographed by placing them on a spatula. We found that the most important factor is depth control since it can differ in different donor area in the same patient. The second important factor is angle of hair that exits from scalp surface. Transection rate is high in acutely angled hairs. Selection of size of Punch is another important factor. Position of the patient, proper lighting, good magnification and skin colour are minor but very important factors. Any compromise with these factors may produce transected grafts. **Results**: FUE is a difficult technique with huge learning curve. Even after 500 procedures our transection rate is still 10% to 15% in some difficult cases with an average transection rate of 5 to 8%. Though a transection rate of 5 to 10% is considered acceptable, one should aim for less than 2% which compares with FUT.

Tricho Cosmetics: O 70 Hair Loss and the Science of Hair Care

Zoe Diana Draelos

North Carolina, USA

Hair loss can be due to medical conditions and cosmetic issues. While hair loss requires a thorough medical evaluation to rule out any underlying health issues, careful grooming and hair care practices can maximize the beauty of existing hair. It is the key to recognize that hair is a nonliving fiber with much of the hair cosmetic technology originating in the textile industry. As individuals age, the diameter of the hair decreases and the hair growth rate slows. Given these facts, hair color and hair shape alterations require that chemicals remain in contact with the hair for a shorter period. Hair is also damaged by UV radiation resulting in the formation of oxymelanin, an oxidative by product of eumelanin. Finally, fibered hair sprays and pigmented powders can be used to temporarily create the illusion of full hair by camouflaging the visible scalp.

O 71: Safety, Efficacy, Quality, and Ethical Issues in Hair Cosmetics

Alain Khaiat

Singapore

When developing a new product, consumer benefit must be well understood and a technical development strategy be devised. But first in mind must be the safety of the ingredients used and of their combination. More important ethical aspects have to be considered as well. We will show what these are and how to develop products that meet the consumer expectations as well as the society expectations.

O 72: Shampoos -- A Critical Appraisal

Abhay Mani Martin

Calicut, India

Shampoos are widely used as hair cleansers. They may be medicated or non-medicated. The harmful effects of shampoos and their consequences on hair structure and biology are poorly understood by the users and practitioners alike. The chemistry, use and misuse, and the pathogenetic factors involved in the damage to hair shafts by shampoos are discussed in this presentation. A critical appraisal will be made on the available products and their usefulness.

O 73: Shampoo Formulations: Basic Composition and How to Choose?

Mhaskar

Mumbai, India

There are many shampoo formulations available. The primary constituents may be similar, but there are many additional components to enhance the efficacy, lather, texture, and many other properties. This paper deals with an overview of the existing products, their primary constituents, special additives, and most essentially, what should the patient or the doctor be concerned while choosing or recommending a shampoo, respectively.

O 74: Hair Camouflage

Kshama P. Vibhakar

Mumbai, India

The aim of this study is to explain the available methods of hair camouflage and understand the effectiveness as well as constraints of these methods to be equipped with the options available for a patient not responding to medical management, not fit for surgical therapy, or for tiding over transient period during hair gain procedures.

Techniques of hair camouflage are:

Change of hairstyleHair wigs or toupees and hair extensions made of human hair, natural fibers, or synthetic fibersHair density enhancing fibers for instant cover up which are synthetic, natural keratin or herbalHair thickening agentsHair transplant using autograft (transplant) or synthetic hair (implants)

The comb over technique may lead to tragically comic results as time passes. Hair wigs and extensions require good patient selection, quality making, proper application, and regular usage care. These are resorted to when there is not much hope of regrowth with a depleted donor area. Instant covering is temporary and lasts till the next hair wash. Hair transplants require good technique and instrumentation and takes long hours of surgery. New hair growth takes 3--4 months. Hair implants are not FDA approved. There is much to discover for a complete hair cover.

O 75: Does Hair Oil Application Worsen Acne?

Nidhi R. Sharma

Navi Mumbai, India

**Background**: Hair oil application has been used in India since ancient times for hair dressing and grooming. This practice is more common in India than in the western countries. We proposed that hair oil application can be an aggravating factor in patients with acne. **Materials and Methods**: We conducted a study on 50 patients attending Department of Dermatology. Twenty-five patients had acne vulgaris and were considered as cases, and the other 25 patients were with diseases other than acne and were considered as controls. A detailed history in the form of a questionnaire was taken of both the groups, mainly regarding hair oil habits like frequency of hair oil application and the type of hair oil used. **Results**: It was found that the case group with acne gave a history of hair oil application 3-7 times a day, with a mean value of 3.9. It was compared to the frequency of hair oil application in the control group, which showed a mean value of only 1.9. Also, few interesting findings were noted in the case group of patients, which were that 60% of these patients had forehead acne, and majority of the patients gave history of coconut, vegetable, or almond oil application. **Conclusion**: So, it was concluded that hair oil application can worsen acne in already predisposed individuals. However, studies in a wider population are required to confirm the findings.

O 76: Tight Caps and Scarfs as a Trigger for Pityriasis Amiantacea? -- A Clinical and Epidemiological Analysis of 232 Cases

Sundaram Rajagopal

Libya

**Background**: Pityriasis amiantacea (PA) is not common in many places, but is common in Mediterranean region. This made me to analyze the epidemiology of this entity. **Materials and Methods**: This was a study of 232 cases of PA attending dermatology OPD in Almarj and Albeida Hospital from June 2001 to January 2011. Seventy-nine were female children, 64 were male children, 47 were adult females, and 42 were adult males. The condition affected females more than males. Some cases showed mild itching with thick adherent and matted hair on the scalp. Few were associated with psoriasis vulgaris, tinea capitis, and seborrheic dermatitis. Most of the cases were asymptomatic with thick silvery adherent scales that surrounded and bound tufts of hair and in overlapping tiles of roof pattern. Scraping and hair root examination for fungus were negative in most of the cases. **Results**: The cause of PA remains obscure. It is representing a particular reaction pattern of the scalp to various inflammatory scalp diseases. Here, in our analysis, probably in adult females, tightly worn synthetic materials may be one of the causes. **Conclusion**: The outcome of PA was usually benign in majority of the cases. Recurrences were common. Less than 26% of cases showed non-scarring alopecia. Most of the cases responded well to betamethasone scalp lotion, clotrimazole solution, ketoconazole shampoo, antihistamines, and topical application of olive oil.

Investigations in Hair Loss: O 77 Decoding the Use on Investigations in Alopecia: What to Use, When to Use, and How to Use?

Punit Saraogi

Mumbai, India

Any case of hair loss should be investigated with a three-pronged approach:

1)Detailed history2)Clinical evaluation methods3)Laboratory and other investigations

Various methods are available for evaluation (for diagnosis and/or quantification) of a patient presenting with hair loss. Hair evaluation methods are grouped into three main categories: Non-invasive methods (e.g. questionnaire, daily hair counts, standardized wash test, 60-s hair count, global photographs, dermoscopy, hair weight, contrasting felt examination, phototrichogram, TrichoScan, and polarizing and surface electron microscopy), semi-invasive methods (e.g. trichogram and unit area trichogram), and invasive methods (e.g. scalp biopsy). Any single method is neither "ideal" nor feasible. However, when interpreted with caution, these are valuable tools for patient diagnosis and monitoring. Daily hair counts, wash test, etc. are good methods for primary evaluation of the patient and to get an approximate assessment of the amount of shedding. Some methods like global photography form an important part of any hair clinic. Analytical methods like phototrichogram are usually possible only in the setting of a clinical trial. Many of these methods (like the scalp biopsy) require expertise for both processing and interpreting. A plethora of newer methods is being introduced, which are relevant to the cosmetic industry/research.

O 78: Hair Pull Test -- A Useful Tool in Assessing Non-patterned Diffuse Alopecia

Betsy Ambooken

Calicut, India

**Background**: Alopecia patterned and non-patterned are common problems encountered in our clinical practice. **Aim**: To assess the usefulness of hair pull in patients who presented with non-patterned diffuse alopecia. **Materials and Methods**: Forty-two female patients who presented with acquired non-patterned hair loss were evaluated by hair pull test as described by A Tosti and B M Piraccinni. The pulled out hairs were subjected to hair microscopy after mounting in DPX. Patients on cytotoxic drugs or following any stressful situation in the previous 4 months were excluded from this study. All patients were evaluated in detail through proper history, examination, and investigations which included blood counts, peripheral smear, liver function tests (LFT), renal function tests (RFT), thyroid function tests, and antinuclear antibody (ANA) test. Specific investigations like S. ferritin, S. zinc, and HIV testing were done if warranted. Those with positive hair pull were again evaluated during follow-up. **Results**: Among the 42 patients, nutritional anemia was found in 8, hypothyroidism in 6, systemic lupus erythematosus (SLE) in 6, alopecia areata incognita in 4, drug induced (sodium valproate) in 3, malabsorption and c/c pancreatitis in 1, and no definite cause in 14. Definitely positive hair pull was present in 13 (30.95%). This included all four with alopecia areata incognita, four with SLE, two with hypothyroidism, two with nutritional anemia, and one with c/c pancreatitis. One patient with hypothyroidism initially presented with features of zinc deficiency. One with alopecia areata incognita was also HIV positive. Hair pull negativity probably indicates a subclinical or less severe form of disease. Three months after treatment, hair pull became negative in all except two. **Conclusion**: It is seen from this series that those with positive hair pull need detailed evaluation. More importantly, it is a useful tool in assessing disease progression as in cases of alopecia areata and to assess treatment response in SLE, hypothyroidism, and nutritional deficiencies.

O 79: Free Testosterone Level 2 and Above: An Earliest Indicator of FPHL in the Absence of Other Signs

Anoosha P. Reddy

Chennai, India

**Background**: Female pattern hair loss (FPHL) or female androgenetic alopecia (FAGA) need not always be patterned. It can present as diffuse hair loss (DHL). It becomes difficult to detect early FPHL because of the polymorphic presentation. Hair diameter variability is also sometimes not clearly evident in early cases of DHL. **Aim**: Our aim was to estimate free testosterone levels in women with hair loss, especially suspected cases of DHL which might progress to FPHL. **Materials and Methods**: A total of 280 women presenting with hair loss were screened for free testosterone levels by enzyme-linked immunosorbent assay (ELISA) using the Diasource kit, India. Questionnaire assessment, clinical examinations including hair pull test, trichoscopy for hair diameter diversity, trichogram, and relevant investigations like thyroid, ferritin were done for all the cases. **Results**: Free testosterone was normal and within the range (0.04--4.18 µg/ml) in almost all the cases except one. The levels were 2 and above in 101 cases. Out of the 101 cases, 32 had Grade 2 Ludwig\'s pattern FAGA, 44 had Grade 1 Ludwig\'s pattern FAGA, and 25 did not have any pattern but only had DHL. Compared to the FAGA group, the DHL group did not have significant hair diameter variability. Women with DHL who had poorly responded to treatment with nutritional supplements earlier started responding well to oral finasteride 5 mg/day and topical minoxidil. **Conclusion**: Free testosterone level of 2 and above appears to be the earliest indicator of FAGA and hyperandrogenism. Estimation of free testosterone in all women with DHL seems to be a wise thing to do in view of early detection of FAGA and prevention of progressive thinning.

Lasers for Hair Growth: O 80: Lasers and Light in Pattern Hair Loss

Ralph M. Trüeb

Zurich-Wallisellen, Switzerland

In the course of the evolutionary loss of our body pelage, maintenance of scalp hair is probably related to our upright walk, with the scalp maximally exposed to ultraviolet radiation (UVR) and in need of effective photoprotection. While the natural selection advantage of pattern hair loss (PHL) in the course of the evolution remains unclear, the result is the loss of natural protection of the scalp from UVR from a gradual decline in visible scalp hair density. A number of pathologic conditions of the scalp are evidently related to UVR, particularly photosensitive diseases affecting the balding scalp and disorders of the photodamaged bald scalp. While the consequences of sustained UVR on unprotected scalp skin are well appreciated, the effects of UVR on the evolution of PHL have largely been ignored. However, clinical and morphologic observations, as well as theoretical considerations suggest that UVR has some negative effect. Since all of these disparate disorders of the balding scalp share the common feature that under some circumstances they are induced or exacerbated by exposure to sunlight, it has been proposed that PHL represents a photoaggravated dermatosis and demands photoprotection. On the other hand, there is evidence that laser and light sources may enhance hair growth, such as observations of psoralen and ultra violet A induced hypertrichosis and paradoxical hair growth from photoepilation. In fact, the ability of lasers to induce hair growth was incidentally noted as early as in 1967 when Mester and colleagues used low-level laser therapy (LLLT) to treat cancer in mice with shaved backs. Since then, hypertrichosis has been recognized to be a possible side effect of laser treatment. First described in 2002 with intense pulsed light therapy, this phenomenon has now been widely acknowledged to occur with an incidence rate ranging from 0.6 to 10% with low fluences and all laser types. It is thought to be the result of suboptimal fluences that are too low to induce thermolysis, but high enough to stimulate follicular growth. Eventually, LLLT has been developed for treatment of PHL. In 2007, the HairMax Laser Comb^®^ received 510(k) clearance from the FDA for the treatment of PHL for males, and in 2011 for females. This clearance means that the device is considered a moderate-risk medical device by the FDA and is thereby solely screened for safety, not efficacy. The HairMax Laser Comb has been tested in a company-sponsored study of 110 male patients with the claim of significant increase in mean terminal hair density when compared to a sham device. Avram and Rogers conducted the first independent blinded study of LLLT and hair growth with seven patients and found that on average, there was a decrease in the number of vellus hairs, an increase in the number of terminal hairs, and an increase in shaft diameter. A consensus written by hair loss experts states that based on anecdotal experience, LLLT, particularly 650-900 nm wavelengths at 5 mW, may be an effective treatment option for patients. This group also found that even if no regrowth was appreciated, patients noted improvement in the texture and quality of hair. From our own experience, we share with the authors' the opinion that LLLT represents a safe and potentially effective treatment option for patients who do not respond or are not tolerant to standard treatment of PHL with minoxidil and/or finasteride. This technology appears to work better for some people than for others. Predictive factors which will most benefit from LLLT are yet to be determined.

**Further Reading**

Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology. 2003;207(4):343-8.

Leavitt M, Charles G, Heyman E, Michaels D. HairMax Laser Comb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283-92.

Brows and Lashes: O 81 Madarosis: A Marker of Many Maladies

Karthikeyan K.

Pondicherry, India

Madarosis is a terminology that refers to loss of eyebrows or eyelashes. This clinical sign occurs in various diseases ranging from local dermatological disorders to complex systemic diseases. Madarosis can be scarring or non-scarring depending upon the etiology. Appropriate diagnosis is essential for management. Follicular unit transplantation has been found to be a useful method of treating scarring madarosis and the procedure relevant to eyebrow and eyelash reconstruction has been discussed. A useful clinical approach to madarosis has also been included for bedside diagnosis. The literature search was conducted with Pubmed, Medline, and Google scholar using the keywords madarosis, eyebrow loss, and eyelash loss for articles from 1960 to September 2011. Relevant material was also searched in textbooks and used wherever appropriate.

O 82: Lashes Lost and Lessons Learnt

Abhay Mani Martin

Calicut, India

Eyelashes are an essential part of ocular anatomy. While adding a glamour quotient to the eyes, they also serve a protective function. Diseases affecting the lashes may occasionally lead to loss of lashes -- both scarring and non-scarring. A case report on the manifestation of eyelash alopecia areata in an 8-year-old girl and insights into its management will be highlighted. The differentials for alopecia of eyelashes and its treatment will be dealt with.

O 83: Over the Top

Ganesh S. Pai

Mangalore, India

For decades, hair, its presence or absence has been a subject of humor, discussion, and fascination. Its excessive presence and absolute absence at both ends of the spectrum make it a subject for a second look. Presented is humor and hair, a mischievously over-the-top presentation of lifeless keratinized strands which have fascinated mankind over centuries.

Interesting Clinical Studies and Controversies -- Most Practical to the Dermato-trichologist: O 84: Evaluation of Diffuse Hair Loss in Women by Clinicopathologic Correlation

Aparna A.D.

Bangalore, India

**Aim**: To study the diffuse hair loss in women both clinically and pathologically, and classify them into different types based on it. **Materials and Methods**: Thirty women with diffuse hair loss attending our out-patient department were evaluated clinically. Patients with scarring alopecia and patchy alopecia were excluded. Routine and relevant investigations were done, and triple scalp biopsies were done. The terminal and vellus hair ratio was assessed to differentiate between female pattern hair loss (FPHL), chronic telogen effluvium (CTE), and telogen effluvium (TE). **Results**: In our study, we found that diffuse hair loss is common in young adults and middle-aged women. Most of the patients present with gradual diffuse hair loss. Clinically, 18 patients were diagnosed as CTE and 12 as FPHL. On histopathology, out of 30 patients, 12 had CTE (T:V = \>10:1), 3 had FPHL (T:V = \<4:!), 2 were indeterminate (T:V = 5/6:1), 1 was trichotillomania, and the rest all were normal. **Conclusion**: Diffuse hair loss is a very common complaint in females. A complete evaluation is essential prior to the initiation of any modality of treatment. Our study highlights the use of histopathology in correlation with clinical assessment for the diagnosis of diffuse hair loss in women.

O 85: Estimation of Serum Ferritin and Thyroid Profile Levels in Patients with Chronic Telogen Effluvium: A Pilot Study

Bhanu Prakash

Bangalore, India

**Objective**: Women in the reproductive age group with all other underlying causes of hair loss being ruled out by history were included and evaluated for the above-mentioned parameters by history taking and the necessary laboratory investigations \[complete blood count (CBC), S. ferritin levels, thyroid profile\], and the results were tabulated. **Materials and Methods**: Thirty-five women were included in the study. Nineteen were working women. The commonest age group was in the third decade. Majority of them (26) had disease for 6--12 months with loss of 100--200 hairs/day. Nine patients had low Hb%. Seventeen had low S. ferritin and seven had low thyroid levels. Sixteen patients admitted having significant levels of stress in their day-to-day activities. Ten had low S. ferritin levels even when their Hb% was normal. Four had low S. ferritin levels and low thyroid levels. Two of them had low Hb%, S. ferritin, and thyroid levels. Significantly, of the 19 working women, 11 had low S. ferritin levels and 3 had hypothyroid levels. **Results and Conclusion**: Significant number of cases had low Hb%, S. ferritin, and thyroid levels in the study group. Anemia, hypothyroidism, and stress are the definite causes to be considered in patients with chronic telogen effluvium. Even when Hb% is normal, it is essential that S. ferritin levels are determined. Working women are more likely to suffer from hair loss and also other contributory factors (anemia hypothyroidism and stress).

O 86: Study of Serum Ferritin and Thyroid Levels as Biomarkers in Chronic Diffuse Alopecia

Sindhura M.

Mysore, India

**Background and Aim**: Alopecia, commonly known as diffuse hair loss, is a non--life-threatening condition, yet has a devastating impact on an individual\'s quality of life. It is very distressing when it affects the scalp hair. Aim of the study is to find the correlation of serum ferritin and thyroid hormone levels in patients with chronic diffuse alopecia. **Materials and Methods**: An analytical study was conducted in the Department of Dermatology for 1 year. All patients with complaints of diffuse hair loss were recruited after excluding them through a questionnaire according to the inclusion criteria. A detailed history and clinical examination of hair with laboratory investigations were done. **Results**: Our study was conducted on 48 patients (35 females and 13 males). The mean age was 25 years (15--35 years). Diagnosis of these patients was mainly telogen effluvium, followed by female pattern hair loss and androgenic alopecia. Statistical analysis was done using SPSS version 16 for windows software. The results showed that 48% (23/48) females with low serum ferritin levels of \<10 ng/mL (normal range 20--150 ng/mL) at mean age 23 ± 4.82 (21--28) years were found to be more affected with diffuse hair loss. Five cases \[10% among the 48% (23) cases\] showed borderline levels of both serum ferritin and hypothyroidism. Serum ferritin showed significant positive relationship with the peripheral blood smear rather than hemoglobin. 69% males (9 among 13) showed higher levels of serum ferritin (normal range 20--300 ng/mL). Hence, they did not show any relation to hair loss along with their thyroid profiles. **Conclusion**: Serum ferritin levels \<10 ng/mL are seen in patients with chronic diffuse alopecia, particularly in women in their second decade. There are no significant changes present in the hemoglobin levels of these patients. Thyroid levels and serum ferritin levels are independent variables which present chronic diffuse alopecia.

O 87: Comparative Assessment of Topical Steroids, Topical Salicylic Acid, and Tacrolimus in Alopecia Areata

P.K. Singh

Agra, India

**Aim**: The aim of this study is to find out the effective modality among the various topical treatments available for the dermatologists. **Materials and Methods**: Sixty clinically diagnosed patients of alopecia areata were selected from outpatient department of the medical college, after evaluating the exclusion criteria. Treatment was given for 3 months continuously and further follow-up was done for 1 month, after dividing them into four groups -- group I (topical 0.05% clobetasol propionate), group II (topical 6% salicylic acid), group III (topical 0.1% topical tacrolimus), and group IV (topical petroleum jelly). Evaluation of patients was done using paired *t*-test and significant result was obtained using unpaired *t*-test. **Results**: 73.3% of group I, 46.6% of group II, 54.3% of group III, and 13.3% of group IV showed significant results. Side effects in the form of dermatitis and hypopigmentation were seen in group II. No patient discontinued from the study. **Conclusion**: This study showed that both topical steroid and tacrolimus were fairly effective in limited variant of alopecia areata.

O 88: Minoxidil versus Facial Hair Growth: All or None Phenomenon

Jagadish P.

Bangalore, India

**Background**: Androgenetic alopecia is the most common cause of hair loss in men and women. Female pattern hair loss (FPHL) begins as a diffuse and progressive thinning of the fronto-parietal area of the scalp. In women, patterned hair loss at any age is socially unacceptable. Facial hypertrichosis has been reported more frequently in females who use topical minoxidil solution for the treatment of patterned hair loss. **Aim**: To evaluate whether facial hypertrichosis in females on minoxidil (2%, 5%, and 10%) is a dose-dependent or an all or none phenomenon. **Materials and Methods**: A study of 100 randomly selected patients with FPHL, who were on minoxidil 2%, 5%, and 10%, was carried out. Results were noted at the end of 3 months, 6 months, and 1 year by means of digital photographs taken at the baseline and at each subsequent visit. **Results**: Of the 100 patients, 10% reported facial hypertrichosis with minoxidil topical application. 5% of the patients discontinued treatment due to the same. Also, our observation showed no facial hair growth in 90% of patients on 2%, 5%, and 10% minoxidil. **Conclusion**: Any female (with/without hyperandrogenic features) may have facial hypertrichosis when on minoxidil. On the other hand, we have patients with 2%, 5%, and 10% minoxidil, with no signs of facial hypertrichosis. Also, in such patients, higher concentrations of topical minoxidil may enhance efficacy.

O 89: Combined Formulation of Minoxidil and Topical Finasteride: A Rational One?

Sandeep M.A.

Bangalore, India

**Objective**: To assess the efficacy and rationale behind using topical 5% minoxidil and 0.1% finasteride combined formulation for treatment of androgenetic alopecia in both males and females. Minoxidil and finasteride topical combination acts in synergy by decreasing the occurrence of hair loss. It encourages growth of new hair by inhibition of dihydrotestosterone (DHT) and promoting vascular endothelial growth factor (VEGF). **Materials and Methods**: One hundred patients (75 males and 25 females) with androgenetic alopecia were graded. They were initially started on topical minoxidil and oral finasteride. Women below the age of 35 years or those who had not completed their family were excluded. Combined formulation treatment was started 6--12 months after initiation of treatment, during the time when patients were stopped on oral finasteride, or had not achieved satisfactory improvement by that time. Photographic re-evaluation was done after 4 months. **Results**: During the subsequent follow-up, 62 males and 22 females obtained objective, subjective, and documented improvement from their previous follow-up. The remaining reported little or no improvement. Side effects, in the form of scalp irritation, were reported by 20 patients, but not warranting discontinuation of therapy. **Conclusions**: Topical combined formulation of 5% minoxidil and finasteride appeared to give sustained improvement as compared to continuation of routine therapy. Patient compliance also increased as the fears and myths regarding oral finasteride are effectively dispelled.

O 90: Platelet-rich Plasma -- A potential Therapy for the Treatment of Androgenetic Alopecia

Shruti Gupta

Bangalore, India

**Aim**: To evaluate the safety and efficacy of platelet-rich plasma (PRP) in the treatment of androgenetic alopecia in males. **Materials and Methods**: Participants were volunteers with AGA grade III--VII (Hamilton Norwood classification), who received six sessions of topical application of 2 ml of PRP following dermaroller at 2--3 week intervals, and were evaluated for 12 weeks. The participants were photographed before and after treatment. **Results**: A total of 13 patients in the age group of 25--35 years were included, of whom 10 had AGA grade VA. One patient each had grade III, VI, and VII. Eleven of 13 showed about 80--90% increase in thickness of hair, along with 25--30% increase in hair density. Patients with AGA grade VI and VII had around 15% and 30% increase in hair thickness and density, respectively. These results were evident both objectively (trichoscan and independent observer\'s evaluation of global photographs) as well as subjectively. Almost all the patients (12 of 13) reported markedly decreased hair fall after only 6 weeks of treatment. Added to the above, 10 patients also saw improvement in hair quality in terms of hair color and texture. No side effects or complications were observed during and after the treatment. **Conclusion**: Thus, PRP is an upcoming safe, easy, and inexpensive modality to treat androgenetic alopecia in males, with minimal occurrence of allergic reactions.

O 91: Supportive Role of Mesotherapy in Male Pattern Hair Loss -- A Retrospective Analysis

Sujit Shah

Kholapur, India

**Objectives**: Mesotherapy delivers different molecules into the epidermis, dermis, or subcutaneous tissue. This is a retrospective result analysis of mesotherapy in our patient series of male pattern hair loss (MPHL), where we have obtained encouraging results. **Materials and Methods**: Study period: October 2010--April 2012. No. of patients: 300, in the age group 20--50 years. Routine work-up: Urinalysis, complete blood count (CBC), blood sugar level, serum ferritin, HIV, T3--T4--thyroid stimulating hormone (TSH), clinical photographs. Criteria for exclusion: HIV, thyroid disorder, anemia (Hb \<10 gm %). Criteria for inclusion: All patients where standard treatment modes (finasteride, minoxidil, vitamin supplements) were used at least for 6 months with unsatisfactory results. Agents used in mesotherapy: Minoxidil, dutasteride, vitamins (A, B1, B2, B3, B5). Frequency of mesotherapy: Every 2 weeks in the first 2 months, every month with Mesogun in the next 4 months. **Results**: Results were usually evident 8--12 weeks after starting the first mesotherapy. The overall hair density and hair thickness started improving. We used clinical photographs for result analysis as an objective tool along with patient feedback. The overall results regarding hair growth were: Poor-30%, satisfactory-50%, and excellent-20%. **Conclusion**: As yet, mesotherapy has not gained the ubiquitous approval of the medical fraternity, probably because of the lack of authentic double-blind trials. Our results suggest that it could be a valuable adjuvant therapy in the management of MPHL. We hope more and more studies will clearly define the role of mesotherapy in future.

O 92: Nonresponders of Alopecia Totalis to DPCP Responding to Addition of Betamethasone Pulse: Breaking the Misconception?

Poonam Pund

Mumbai, India

Mainstay of treatment for alopecia totalis (AT) is administering contact sensitizers or oral steroids. Efficacy of diphenylcyclopropenone (DPCP) varies from 17 to 40% in different studies. A 19-year-old boy had total baldness on the scalp except few terminal hairs since 5 years. Pull test was negative. He reported history of alternative treatment taken before without success. The patient was sensitized with DPCP 2% on the occipital area. After 15 days, DPCP was started in the lowest (0.001%) concentration and concentrations were increased consecutively to 0.01% and 0.1% for achieving therapeutic response in the form of mild erythema. After mild erythema developed at 0.1% concentration, he was maintained on the same concentration for 6 months. Even after 6 months of this treatment, the patient showed no hair growth. Therefore, minipulse betamethasone 0.1 mg/kg/week was added. Within 2 weeks of betamethasone pulse, he showed new hair growth. Therefore, DPCP was applied on right side of scalp from midline, continuing the systemic steroids to see the effect of combination therapy. Left side of scalp served as control. Within 6 weeks of treatment, his DPCP treated side showed complete regrowth while the left side responded poorly. Contrary to the belief of dermatologists that steroids negate the effect of contact sensitizers, this case report has proved that systemic steroids actually augment the effect of contact sensitizers.

Sensitive Scalp: O 93 Red Scalp

Ralph Trueb

Zurich, Switzerland

Red scalp disease is a common complaint and therapeutic challenge encountered in daily clinical practice. It was originally reported by Thestrup-Pedersen and Hjorth in 1987, and subsequently commented on by Moschella in 1994 who described the difficult problem of "diffuse red scalp disease which can also be itchy and burning, is nonresponsive to any therapy including potent topical steroids or antiseborrheic therapy." By definition, the complaint cannot be related to any specific dermatologic disease typically affecting the scalp on careful examination, such as eczema or psoriasis. Later, Grimalt presented findings in 18 patients with "red scalp syndrome" at the 2000 Annual Meeting of the EHRS, and found an association with hair loss due to androgenetic alopecia in the majority of cases, leading to speculations over the role of chronic UV exposure of the balding scalp. Moreover, dilated and tortuous vessels are typically found in photodamaged skin. Other pathogenetic speculations have concerned perifollicular inflammation and increased expression of the neuropeptide substance P in the vicinity of affected hair follicles. These findings suggest a connection between sensory or subjective irritation and cutaneous vascular reactivity. More recently, we found a correlation of telangiectasia of the scalp with the presence of scalp discomfort, and proposed an analogy to the observation that patients with a telangiectactic type of rosacea respond more frequently with stinging sensations to the topical application of 5% lactic acid on the cheeks than patients with the papulopustular type of rosacea or normal controls. Eventually, our observation of two cases of red scalp disease with clinical and histopathologic findings consistent with rosacea and response to oral tetracycline therapy suggests that at least a subset of patients with red scalp represent a rosacea-like dermatosis of the scalp. Besides oral tetracycline therapy, topical corticosteroids are to be prevented, and patients are to be recommended protection of the scalp from UV exposure.

O 94: Itchy Scalp

Chakravarthy R. Srinivas

Coimbatore, India

Itching is a common complaint encountered by us. It was long believed that itching and pain are both mediated by pain fibers, but it is now known that itching is mediated by unmyelinated C fibers and A delta fibers in the lower epidermis and upper dermis. Itch receptors in the nerve endings are superficially located, whereas receptors for pain are located both in superficial dermis and deep dermis. The C fibers synapse with secondary order neurons in the gray matter of dorsal horn, cross and ascend the lateral spino-thalamic tract to thalamus and then to anterior singular and in singular cortex. Although histamine is the commonest mediator, histamine-independent pruriceptive "C" fibers can stimulate itch by mechanical, electrical stimulus and specks of cowhage. Histamine mediates through H~1~, H~2~, H~3,~ and H~4~ receptors located in the nerve endings. H~3~ is more related to pain. The itch-mediating cytokines include interleukin (IL)-1, IL-2, Prostaglandin E, etc. It is commonly seen that both cold and heat relieve itching. This is due to activation of Transient Receptor Potential (TRP) family receptors. TRPM-8 and TRPA-1 act on C and Ad fibers and are stimulated at 8--28°C. Menthol activates TRPM-8. TRPVI, the Capsaicin Receptor, is activated at low PH (\<5.9) and at \>42°C. The anesthesia one feels by spirit, acetone, ice, or LN~2~ spray is possibly due to activation of TRM-8 receptor. Histamine released by mast cells acts on the keratinocyte to produce Nerve Growth Factor (NGF) which increases the size of free nerve endings in atopic dermatitis. Scalp pruritus can be due to many causes -- some known and some less known and less understood. The common causes include tinea capitis, pityriasis capitis, seborrheic dermatitis, psoriasis, atopic dermatitis, lichen simplex chronicus, contact dermatitis, dermographism, etc. Seborrheic dermatitis can be triggered by immune incompetence, and deficiencies such as of riboflavin, biotic, etc. It is associated with Parkinsonism, epilepsy, spinal cord injury, and AIDS. I have seen systemic scleroderma presenting as scalp pruritus. Treatment rests on administering creams, shampoos, tars, ketoconazole, and topical steroids, along with oral antihistamines as they are the most commonly used drugs. Anxiolytics, antidepressants, vitamin supplements, and antiepileptics are needed at times. To conclude, scalp pruritus is a common problem. Treatment depends on etiology. Empirical therapy is often needed, and reassurance and hand holding is just as helpful as are drugs.

O 95: Sensitive Scalp -- A Real Entity?

Kiran Godse

Mumbai, India

Sensitive skin is defined (Grades 1-4) as the onset of prickling, burning, or tingling sensations (possibly pain or pruritus) caused by various factors which may be physical (ultraviolet radiation, heat, cold, and wind), chemical (cosmetics, soap, water, and pollution), psychological (stress), or hormonal (menstrual cycle). A 35-year-old female presented with sensitive scalp and hair loss since 2 weeks and complained of pain on touching the scalp and stinging sensation on the vertex area of scalp. Patient had undergone herbal oil treatment for hair loss, which involves use of hot oil massage and oral medications. A 30-year-old male presented with sensitive scalp and hair loss since 20 days, who had also used herbal oil for hair growth for male pattern baldness. Patient gave history of stinging and burning sensation on the scalp. Earlier, he had been prescribed alcohol-based minoxidil lotion for hair growth, which worsened the symptoms. Both our patients presented with sensitive scalp which often goes undetected in patients. Such patients cannot tolerate alcohol-based minoxidil lotion. Foam or water-based minoxidil lotion is less likely to irritate the scalp.

Hirsutism and Lasers for Hair Removal: O 96 The Etiology of Hirsutism

Valerie Anne Randall

Bradford, UK

Hirsutism, excessive hair growth in women in a male pattern, causes psychological distress and decreased quality of life. This is because the main role of the additional hair developed during, and after, puberty is social and sexual communication. Pubic and axillary hair signals adulthood in both sexes, while beard, chest, and other body hair identifies the sexually mature male. This means that a woman with hirsutism may feel she is turning into a man. Most patients with hirsutism present with terminal (readily visible, pigmented) hair on the moustache and chin areas; this may be accompanied by hair on the chest, abdomen, and thighs. The amount of increased visible hair that is unacceptable varies with cultural/ethnic background. Hirsutism may be associated with other signs linked to androgens such as acne or androgenetic alopecia or acanthosis nigricans (dark patches of skin). Androgens are the usual stimulant for adult human hair growth patterns and are strongly implicated in hirsutism. Hirsutism can be caused by endocrinologic changes including increased androgen production by the adrenals or ovaries and is often associated with polycystic ovarian syndrome (PCOS). Sudden, dramatic onset requires urgent endocrine investigation as it may indicate an androgen-secreting adrenal or ovarian tumor. Although raised circulating androgen concentrations or low sex hormone binding globulin levels are common, some hirsute women do not show obvious causes, i.e. are idiopathic. This is likely to involve an increased sensitivity to normal androgens within the hair follicles themselves. Greater understanding of how androgens act within the hair follicle should lead to better treatments for hirsutism.

O 97: Lights, Lamps, and Lasers -- What, When, and Where, and Therapeutic Hair Removal

Ganesh Pai

Mangalore, India

The last decade has brought in a spurt of new laser systems alongside a clutch of new technologies. Lasers of various frequencies, in-motion techniques, and IPLs for hair reduction are in use at various centers around the world. Efficacy, choice of technology, and their application are discussed in this lecture.

O 98: Optimizing Laser Hair Reduction Outcomes in the Hirsute

Rajetha Damisetty

Hyderabad, India

Laser hair reduction is one of the most commonly performed interventions, be it for true hirsutism or for socially unacceptable facial and body hair. It is important to understand the factors that influence outcomes to obtain optimal results and incorporate them into the protocol. In hirsute women, one of the most important factors is the androgen excess which may be in the circulation or just at the tissue receptor level. The shortcomings of ultrasonography of the pelvis through the abdominal route in the presence of excess abdominal fat, the subjectivity involved in USG, the androgen to be measured, the assay method used, and repeating apparently "normal" investigations at periodic intervals influence the diagnostic label. Irrespective of the menstrual history, a transvaginal ultrasound in all married women, preferably with measurement of ovarian stroma/total ovarian volume ratio along with serum free testosterone assay on day 3--5 of the menstrual cycle and serial ultrasonography at 6-month intervals increased the diagnostic yield of polycystic ovarian syndrome (PCOS). Long pulsed Nd YAG and advanced fluorescence technology (Alma Lasers) were used, giving adequate gap between sessions to maximize the amount of anagen hairs at the time of the session. A strict protocol of using maximal tolerable fluences during every session, instituting hormonal medications (drosperinone--ethinyl estradiol combination) before the second session of laser hair reduction and adding spironolactone to all those with moderate and severe hirsutism, aided in obtaining satisfactory results. Metformin for the insulin-resistant and lifestyle changes aimed toward normalizing body mass index (BMI) were integral part of the protocol.

O 99: Diode Laser for Trichostasis Spinulosa of Nose

Dhananjay Krishnaraj Chavan

Kholapur, India

**Background**: Trichostasis spinulosa (TS) is a common but probably underdiagnosed follicular disorder in which multiple hairs in a keratinous sheath project above the skin surface. Current treatments provide temporary relief with a lot of side effects. We report the successful treatment of TS in 8 patients using a diode laser. **Materials and Methods**: No. of patients: 15, in the age group of 20--40 years (11 females and 4 males), with lesions on nose Duration 3--6 years, skin types IV--V. Work-up: KOH preparation, clinical photographs. Laser used: Diode (810 nm); pulse duration (30 msec); fluence (22--26 mj); spot size (9×9); no. of passes (2--3); Sapphire tip contact cooling; no anesthesia. Frequency: Two sittings at 2 months interval. Follow-up for one year after second laser sitting. **Results**: Seven patients had complete clearance of lesions, whereas one male patient had partial recurrence after 6 months, which needed another laser session. **Conclusion**: Current non-laser treatment modalities of TS provide temporary relief with frequent side effects. We have been able to achieve excellent results with Diode laser without any untoward side effects. TS is a common malady and could be easily managed with the help of Diode laser.

New Concepts and Novel Methods: O 100: New Concepts in Hair Care

Zoe Diana Draelos

North Carolina, USA

The hair damage cycle must be interrupted for hair health to be restored. Hair damage is initiated by uplifting of the cuticle that then leads to cuticle loss and fracture of the underlying cortex and medulla. The cuticle provides strength to the hair shaft covering the weak cortex and must therefore be protected at all costs. Most hair conditioners create their effect by smoothing the cuticular scales. Activities that damage the cuticle include back combing, teasing of the hair, hair dying, permanent hair straightening, and hair permanent waving. With continued exposure to the elements, known as weathering, the hair shaft loses proteins, especially those containing sulfur. The sulfur-containing proteins provide hair shaft strength and are altered during permanent waving and straightening procedures. Protein-containing conditioners attempt to diffuse proteins into the hair shaft and may strengthen the hair by 5%. Avoidance of hair cuticle loss is the key to healthy hair.

O 101: Prostaglandins --"Drugs with a Bidirectional Effect"

Anoosha P. Reddy

Chennai, India

This article reviews the usefulness of prostaglandins in trichology. As we all know, too much or too little of anything is not good. It is the same with hair. Both hirsutism and androgenetic alopecia are bothersome to the patient. Here\'s a novel therapeutic molecule which can sort out both problems. Prostaglandins (Pgs) are the metabolites of the arachidonic acid pathway. PgD2 is known to be inhibitory on hair growth, while PgE2 and PGF2 are known to promote hair growth. Thereby, these prostaglandins are being made use of for various conditions. Latanoprost, a PgF2α, has been proven to be effective in treating eyelash alopecia areata. Latanoprost has also been given as mesotherapy for androgenetic alopecia and has been found very useful. Bimatoprost, a prostamide with antihypertensive properties, has been found to produce luxurious eyelashes. It has also been tried in female Androgenetic alopecia with fairly good results. While on the other hand, PgD2, which is chiefly produced by mast cells and the brain, has been found in high levels in the balding scalp tissue than in the non-balding scalp tissue. So, a new school of thought is that this PgD2 can be used to treat hirsutism due to its inhibitory effects on hair growth. Hence, both issues can be dealt with using these magical molecules.

O 102: Does the Prostamide-related Glaucoma Therapy, Bimatoprost, Offer a Novel Approach for Treating Scalp Alopecia?

Valerie Anne Randall

Bradford, UK

Minoxidil (Regaine/Rogaine), the most common topical treatment for hair loss, was originally developed as an anti-hypertensive drug. Its use for alopecia occurred serendipitously due to its stimulation of unwanted hair growth when taken orally. More recently, some prostaglandin- and prostamide-related drugs used to treat raised intraocular pressure in the eye disease, glaucoma, have been reported to stimulate eyelashes as a side effect. One of these, bimatoprost, a prostamide F~2~α analog, is now licensed by the Food and Drug Administration (FDA) in the USA for the treatment of hypotrichosis of the eyelashes. Prostamides are a recently discovered group of biological lipids, related to prostaglandins but with an additional ethanolamide group, which target specific receptors. Since topical treatment of eyelashes has such pronounced effects on growth, bimatoprost may have the potential to stimulate scalp follicles and relieve scalp alopecia. However, eyelash follicles produce very specialized hairs and have marked differences in their biology to scalp hair follicles. In particular, they differ in their response to the main regulatory signaling molecules, the androgens, which have no obvious effect on eyelashes unlike their inhibition of scalp hair follicles. To see whether bimatoprost could also stimulate non-eyelash hair follicles, we investigated whether human scalp or mouse pelage hair follicles could respond. Bimatoprost stimulated hair growth in scalp follicle organ culture and advanced mouse hair regrowth *in vivo*, i.e. its effects mirrored those of bimatoprost on eyelashes *in vivo*. Receptors were also identified in human scalp follicles *ex vivo* using molecular biological methods and located in the key regulator, the dermal papilla. All these suggest that bimatoprost should stimulate human scalp hair follicle growth in vivo and offer a novel, low risk approach for scalp alopecia therapy.

O 103: Patterned Hair Loss -- Newer Solutions

Aparna Santhanam

Mumbai, India

Hair loss remains the single most unmet need of patients the world over and an effective solution continues to be an illusion. While most of the products available today for androgenic hair loss offer multiple combinations of actives, very few comparative clinical trials have been conducted. A multi-mechanistic combination of actives was developed after selection on potent actives screened through *in vitro* cell assays. These actives were then formulated into a topical product which was compared to minoxidil in a randomized, double-blind, cross-over clinical trial on 100 subjects. The results will be shared and some new evaluations for early sign of efficacy will be discussed.

O 104: Concept of Platelet-rich Plasma

Rachita Durat

Mumbai, India

Platelet-rich plasma (PRP) is obtaining the maximum concentration of platelets in a small volume of plasma. Its utility is well documented in wound healing, facial rejuvenation, and recently in hair regrowth. PRP is prepared by two methods -- cytopheresis and buffy coat. There are various commercially available kits and tubes of PRP prepared from buffy coat method, which are expensive. However, there is no standard procedure followed for the preparation of PRP, and hence the yield varies with respect to the method of preparation. In cytopheresis method, PRP is prepared by double spin which includes slow spin and fast spin. During the spin, maintenance of a proper "G," i.e. relative centrifugal force, is of utmost importance. Also, maintenance of optimal temperature of the centrifuge machine is vital as platelets can get activated due to the heat generated during revolutions. Choosing the proper anticoagulant is necessary for a better yield as ethylenediaminetetraacetic acid (EDTA) damages the cell wall of platelets, and hence acid citrate dextrose (ACD) or citrate phosphate dextrose acetate (CPDA) is preferred. After the first spin, two layers are formed, RBCs at the bottom and plasma on top of them. This plasma is separated out and transferred to the special tubes. After the second spin, lower half of the tube contains PRP and upper half is of platelet-poor plasma. The platelet concentrate in PRP should ideally be 4--5 times the baseline value. Activation of platelets is important for the release of growth factors from alpha granules, which is done by thrombin/calcium.

O 105: Mirror Neurons -- The Mirror of Future?

Sreekanth S.

Kerala, India

Mirror neurons are neurons that discharge during the execution of actions and also during the observation of the same actions performed by other individuals. Such neurons were discovered in primates in early 1990s. But, their practical and therapeutic importance in humans was realized only later. The significance of mirror neurons in psycho-dermatology and psycho-trichology still remains as unexplored terrains, and is aimed here to be explored judiciously. Articles and studies about mirror neurons, in various disciplines including neurology and psychology, are analyzed in this background. Many researches have linked mirror neurons to the understanding of intentions, behavior, and mental state of others, empathy on seeing another person experiencing an emotion, development of languages, automatic imitation, and gender differences in emotions. Studies have shown good results when repeated action observation by video demonstrations or watching the movements of opposite normal limb by specially made "mirror box" was used for training patients with motor impairment after stroke. Virtual massage by observing limb massage action and "mirror box" exercise have been shown to relieve chronic pain syndromes like "phantom limb pain" and "complex regional pain syndrome." Studies are required to know whether repeated watching of video demonstrations of hair combing and caressing actions will help in disorders with tendency to destroy hair and also whether virtual massage can control the tendency to scratch in neurodermatitis. Stress reduction techniques also may be developed using mirror neuron principle. Both the possible therapeutic implications and the insight given by mirror neurons into human "psyche" cannot be ignored.

O 106: Ultrasound: A Non-invasive Tool to Study Inflammation of the Scalp

Rakesh Bharati

Punjab, India

Ultrasound has gained popularity as a non-invasive tool to assess various changes in the skin physiology as a response to extrinsic and intrinsic factors. We used ultrasound to study the benefit of oiling on scalp health. Epidermal thickness and the hypoechoic band were used as markers for the same.

O 107: Confocal Studies for Evaluation of Penetration of Hair Care Actives

Vaishali Gode

Mumbai, India

Confocal microscopy has been used effectively to study the penetration of various compounds into both the hair follicle and the hair shaft. This technique can also be effectively used to study the penetration of hair oil and check if the hair oils are truly functional or just provide a lubricating benefit.

Evidence-based Trichology: O 108 Role of Evidence in Successful Trichological Practice

Ralph Trueb

Zurich, Switzerland

Evidence-based medicine (EBM) aims to apply the best available evidence gained from the scientific method to clinical decision making. It seeks to assess the strength of the evidence of risks and benefits of treatments and diagnostic tests. Using techniques from science, engineering, and statistics, such as the systematic review of medical literature, meta-analysis, risk-benefit analysis, and randomized controlled trials (RCTs), EBM aims for the ideal that healthcare professionals should make conscientious, explicit, and judicious use of current best evidence in their everyday practice. EBM recognizes that many aspects of health care depend on individual factors such as quality- and value-of-life judgments, which are only partially subject to scientific methods. EBM, however, seeks to clarify those parts of medical practice that are in principle subject to scientific methods and to apply these methods to ensure the best prediction of outcomes in medical treatment, even as debate continues about which outcomes are desirable. Although EBM is becoming regarded as the gold standard for clinical practice, there are a number of limitations of its use. EBM guidelines do not remove the problem of extrapolation to different populations or longer timeframes. Even if several top-quality studies are available, questions always remain about how far, and to which populations, their results may be generalized. Certain groups have been historically under-researched, such as racial minorities and people with many co-morbid diseases, and thus the literature is sparse in areas that do not allow for generalizing. EBM applies to groups of people, but this does not preclude clinicians from using their personal experience in deciding how to treat each patient. *Ex cathedra* statements by the medical expert are considered to be the least valid form of evidence. Nevertheless, knowledge gained from clinical research does not directly answer the primary clinical question of what is best for the patient at hand and suggests that EBM should not discount the value of clinical experience. Good medical practice means integrating individual clinical expertise with the best available external clinical evidence from EBM. A liaison with patients, respect for their individuality, and professional expertise are preliminary to creating the atmosphere of mutual trust, which on one side, enables the physician\'s professional contribution to the healing process, and on the other side, assists patients to draw also from their own mental self-healing capacities. This is where, at times, success in treating hair loss disorders may supersede EBM. The trichological patient expects more than a 63% chance of success with topical minoxidil in treatment of female androgenetic alopecia, more than temporary success in alopecia areata, and more than merely halting the disease process in the inflammatory scarring alopecias. It is that difference which has to be found out and cultivated that determines whether or not the patient will belong to the 63% responders to minoxidil, whether or not treatment of alopecia will be successful and long lasting, and whether or not regrowth of hair may be seen in the inflammatory scarring alopecias.
